<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Nutr</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Nutr</journal-id>
<journal-id journal-id-type="publisher-id">Front. Nutr.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Nutrition</journal-title>
</journal-title-group>
<issn pub-type="epub">2296-861X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32582754</article-id>
<article-id pub-id-type="pmc">7290048</article-id>
<article-id pub-id-type="doi">10.3389/fnut.2020.00081</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Nutrition</subject>
<subj-group>
<subject>Hypothesis and Theory</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>PTEN: A Thrifty Gene That Causes Disease in Times of Plenty?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Venniyoor</surname>
<given-names>Ajit</given-names>
</name>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/367401/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff><institution>Department of Medical Oncology, National Oncology Centre, The Royal Hospital</institution>, <addr-line>Muscat</addr-line>, <country>Oman</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Maurizio Muscaritoli, Sapienza University of Rome, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Sharon Ross, National Cancer Institute (NCI), United States; Alessio Molfino, Sapienza University of Rome, Italy</p>
</fn>
<corresp id="c001">*Correspondence: Ajit Venniyoor <email>avenniyoor@gmail.com</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Clinical Nutrition, a section of the journal Frontiers in Nutrition</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>7</volume>
<elocation-id>81</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>2</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Venniyoor.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Venniyoor</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The modern obesity epidemic with associated disorders of metabolism and cancer has been attributed to the presence of “thrifty genes”. In the distant past, these genes helped the organism to improve energy efficiency and store excess energy safely as fat to survive periods of famine, but in the present day obesogenic environment, have turned detrimental. I propose PTEN as the likely gene as it has functions that span metabolism, cancer and reproduction, all of which are deranged in obesity and insulin resistance. The activity of PTEN can be calibrated <italic>in utero</italic> by availability of nutrients by the methylation arm of the epigenetic pathway. Deficiency of protein and choline has been shown to upregulate DNA methyltransferases (DNMT), especially 1 and 3a; these can then methylate promoter region of PTEN and suppress its expression. Thus, the gene is tuned like a metabolic rheostat proportional to the availability of specific nutrients, and the resultant “dose” of the protein, which sits astride and negatively regulates the insulin-PI3K/AKT/mTOR pathway, decides energy usage and proliferation. This “fixes” the metabolic capacity of the organism periconceptionally to a specific postnatal level of nutrition, but when faced with a discordant environment, leads to obesity related diseases.</p>
</abstract>
<kwd-group>
<kwd>PTEN (phosphatase and tensin homolog deleted on chromosome 10)</kwd>
<kwd>thrifty gene hypothesis</kwd>
<kwd>insulin resistance</kwd>
<kwd>carcinogenesis</kwd>
<kwd>polycystic ovarian disease (PCOD)</kwd>
<kwd>diabetes mellitus</kwd>
<kwd>NAFLD</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="160"></ref-count>
<page-count count="13"></page-count>
<word-count count="11817"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>In the early sixties, Neel (<xref ref-type="bibr" rid="B1">1</xref>) suggested that evolution has selected some populations for “thrifty genes” to survive cycles of famines but these genes are now proving detrimental in an age of overabundance, leading to modern diseases such as obesity, metabolic syndrome, and cancer. Many genes have been proposed as the putative thrifty genes [see review by Prentice et al. (<xref ref-type="bibr" rid="B2">2</xref>)] but the evidence for a specific gene alteration generating a thrifty genotype is inconclusive (<xref ref-type="bibr" rid="B3">3</xref>). Hales and Barker (<xref ref-type="bibr" rid="B4">4</xref>) suggested a developmental alternative (30 phenotype)—that the fetus, when exposed to poor nutrition undergoes programming <italic>in utero</italic> to survive anticipated nutrition constraints in the post natal nutrition-poor environment also, but develops disease if the post natal environment is nutrition-rich. This has been backed with epidemiological data (such as birth records in England) and is the basis for the Developmental Origins of Health and Disease (DOHaD) concept (<xref ref-type="bibr" rid="B5">5</xref>–<xref ref-type="bibr" rid="B7">7</xref>). The role of epigenetics in programming the genome has gained prominence more recently and the argument has been made for a “thrifty epigenotype” (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>The criteria for a potential thrifty gene has been laid out (<xref ref-type="bibr" rid="B2">2</xref>) and a crucial property is energy efficiency—to reduce energy expenditure and store excess energy in anticipation of periods of famine.</p>
</sec>
<sec id="s2">
<title>The Obesity Epidemic</title>
<p>The classical hypothesis that the basis of obesity is energy imbalance (calorie in, calorie out) does not explain various features of the obesity epidemic [for excellent discussions, read (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>)]. The “carbohydrate-insulin model” of obesity suggests that the primary defect lies in fat storage; excess fat storage causes obesity first which is followed by increased intake (hunger) and reduced activity. Excess fat storage is driven by hyperinsulinemia [which in turn is driven by high glycemic index foods and food additives in processed foods (<xref ref-type="bibr" rid="B11">11</xref>)]. Insulin is essentially an anabolic hormone whose metabolic function is to store absorbed glucose as glycogen and fat. Food with high glycemic index (sugary and processed) that is widely available as part of the Western diet causes a spike in insulin which deposits glucose as fat (causing obesity with hypoglycemia and increasing hunger). Insulin also stimulates <italic>de novo</italic> lipogenesis (DNL), which is a feature of fatty liver; the latter can also be produced by fructose (from high sugar intake) metabolism in liver (<xref ref-type="bibr" rid="B12">12</xref>). It follows that any alteration that makes the insulin-glucose pathway more active will result in efficient fat storage, even at low or normal insulin levels. PTEN is a protein that sits astride the metabolic [phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) (PI3K-AKT-mTOR)] pathway of insulin and suppresses it. Reduced activity of PTEN will smoothen the passage of signals along this pathway, causing “relative hyperinsulinemia.”</p>
</sec>
<sec id="s3">
<title>Hypothesis</title>
<p>It is proposed that PTEN is the primary thrifty gene. Epigenetic changes <italic>in utero</italic> due to deficiency of specific nutrients is the basis for fetal programming for a nutrient-poor postnatal environment. The modern epidemic of metabolic diseases and obesity related cancers (ORCs) results when a PTEN deficient organism, programmed for a nutrient-poor environment, with limited metabolic capacity, is exposed to nutrient-rich surroundings.</p>
</sec>
<sec id="s4">
<title>The Gene</title>
<p>PTEN (phosphatase and tensin homolog deleted on chromosome 10) (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>) was initially recognized as a tumor suppressor gene (TSG); it acts by suppressing the PI3K-AKT-mTOR proliferative pathway through its lipid phosphatase activity, therefore inhibiting cell proliferation. It was later found to be involved in a wide spectra of other cellular processes including energy metabolism (as it sits downstream of the insulin pathway and negatively regulates it, and also alters mitochondrial functioning), survival, proliferation, and cellular architecture. PTEN has certain interesting properties such as (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>):</p>
<list list-type="simple">
<list-item>
<p>- It is dominant negative: the inactive PTEN mutants hetero-dimerise with wild-type PTEN and reduce its phosphatase activity.</p>
</list-item>
<list-item>
<p>- It is haploinsufficient: One copy of the gene is insufficient for proper function. Loss-of-function mutation results in a situation where the amount of protein product created from the remaining wild-type allele is not sufficient for normal cellular function.</p>
</list-item>
<list-item>
<p>- It is quasi-insufficient (<xref ref-type="bibr" rid="B17">17</xref>): it cannot sustain adequate biological functions upon a subtle reduction in the protein levels. Marginal reductions in PTEN expression (“dose”) (<xref ref-type="bibr" rid="B18">18</xref>) along the mitogenic pathway gives rise to a variety of cancers; this hypothesis implies that similar dose modifications can exist along the metabolic pathway with lower doses making the pathway more efficient (resulting in storage of more fat at equivalent levels of insulin).</p>
</list-item>
</list>
<p>The expression and function of PTEN can be modified in a variety of ways, ranging from gene mutations, epigenetic regulation by promoter methylation, post transcriptional modifications and by microRNAs (<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>It is proposed that deficiency of specific nutrients (proteins especially methionine, and choline) leads to upregulation of DNA methyltransferases (DNMT3a, possibly DNMT1) by hypomethylation; this leads to promoter methylation of PTEN and varying degrees of suppression (proportional to the availability of the specified nutrients), resulting in fetal programming. Thus, nutritional supply decides the degree of PTEN expression (“dose”) and the thrifty phenotype, but when faced with post natal nutrition-rich environment, can lead to modern diseases such as metabolic syndrome and cancer.</p>
<p>There are certain questions that need to be answered in support of this hypothesis.</p>
<list list-type="order">
<list-item>
<p>Is it the calorie restriction <italic>per se</italic> or lack of specific nutrients that lead to epigenetic changes? Interest in the field of nutritional epigenetics is expanding and there are multiple epidemiological studies and experimental animal models addressing the fetal and transgenerational outcomes of maternal dietary manipulation. Epigenetic changes, especially DNA methylation, in response to changes in maternal nutrition has been well documented (<xref ref-type="bibr" rid="B20">20</xref>). Calorie restriction <italic>per se</italic> has been noted to lead to changes in gene expression (notable research being carried out in the hope of extending life span) but current interest is in teasing out the specific components of diet that contribute to altered gene expression. The current concept of “protein leverage (<xref ref-type="bibr" rid="B21">21</xref>) suggests that most important part of diet is protein, especially the essential amino acid methionine, and the body can sense and respond to protein and methionine deficiency (via FGF21) (<xref ref-type="bibr" rid="B22">22</xref>). However, methionine levels are tightly controlled in the fetus (<xref ref-type="bibr" rid="B23">23</xref>) as befitting its importance, and other one-carbon donors such as choline and folates can step in as needed to regulate DNA methylation (<xref ref-type="bibr" rid="B24">24</xref>). It is thus suggested that choline is also an important factor in fetal (mal)nutrition that decides the degree of methylation of PTEN and thus the level of its protein expression. Consistent with this hypothesis, maternal low protein diet produced low Pten expressing mouse mammary Tumors in the offspring (<xref ref-type="bibr" rid="B25">25</xref>). The effect of low protein or low choline on normal tissue has not been reported to my knowledge.</p>
</list-item>
<list-item>
<p>Which are the DNA methyltransferases (DNMT) sensitive to nutritional changes? DNMTs are responsible for methylation of promoter regions and usually repress gene expression; the main ones are DNMT1, 3a and 3b. DNMT3a is consistently upregulated in calorie (<xref ref-type="bibr" rid="B26">26</xref>), protein (<xref ref-type="bibr" rid="B27">27</xref>–<xref ref-type="bibr" rid="B29">29</xref>), methionine (<xref ref-type="bibr" rid="B30">30</xref>), and choline deficient states (<xref ref-type="bibr" rid="B31">31</xref>). Gong et al. reported that both the expression levels of DNMT1 and DNMT3a were significantly increased when pregnant rats were fed a low-protein diet (<xref ref-type="bibr" rid="B27">27</xref>). Choline deficient diet in mother resulted in upregulation of both Dnmt1 and 3a in offspring in another study (<xref ref-type="bibr" rid="B31">31</xref>). There are multiple studies using combination deficiencies such as the choline deficient, amino acid defined (CDAA) diet (<xref ref-type="bibr" rid="B32">32</xref>), methionine-choline deficient (MCD) (<xref ref-type="bibr" rid="B33">33</xref>) diet and folate-methyl deficient (FMD) (<xref ref-type="bibr" rid="B34">34</xref>) models where the results are generally consistent with upregulation of one or both DNMTs.</p>
</list-item>
<list-item>
<p>Does alteration in maternal diet lead to changes in PTEN expression in the offspring? As mentioned above, low protein diet in dams can result in downregulation of PTEN in the offspring mammary Tumors (<xref ref-type="bibr" rid="B25">25</xref>). Food restriction <italic>per se</italic> has been shown to downregulate Pten in fetal liver (<xref ref-type="bibr" rid="B35">35</xref>). However, in another study of calorie restriction, Pten expression was not changed in skeletal muscles (though Akt was activated) (<xref ref-type="bibr" rid="B26">26</xref>). Methionine restriction (MR) has also been shown to keep PTEN inactive by reducing the amount of GSH need to keep it in an active, reduced state (<xref ref-type="bibr" rid="B30">30</xref>). Choline deficiency downregulated the expression of Pten in the liver of mice fed choline deficient, amino acid defined (CDAA) diet (<xref ref-type="bibr" rid="B32">32</xref>). (Note that the latter studies were in adult mice; the effect of choline deficient maternal diet on offspring has not been studied to my knowledge). This is consistent with the fact that choline deficient diet leads to non-alcoholic fatty liver disease (NAFLD); a condition known to be associated with PTEN downregulation (<xref ref-type="bibr" rid="B36">36</xref>). However, the classical MCD (methionine-choline deficient) diet model of NASH is associated with PTEN upregulation in murine liver (<xref ref-type="bibr" rid="B37">37</xref>) [while a high fat diet (HFD) model of NASH results in downregulation of PTEN in liver (<xref ref-type="bibr" rid="B38">38</xref>)]. Interestingly, PTEN deficiency in adipose tissue protects against NAFLD (<xref ref-type="bibr" rid="B39">39</xref>), suggesting that the resultant more efficient insulin action could lead to preferential fat storage in adipose tissue, sparing ectopic fat deposition in liver. The expression and function of PTEN appears to be thus tissue and context dependent.</p>
</list-item>
<list-item>
<p>Has calorie/nutrient restriction been shown to result in downregulation of PTEN? There are large data sets from the survivors of famines [such as Dutch Winter Hunger (<xref ref-type="bibr" rid="B40">40</xref>), Chinese (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>) or Bangladeshi (<xref ref-type="bibr" rid="B43">43</xref>) famines] but the published data sets do not include status of PTEN. There is, however, evidence from cell lines and animal models.</p>
<list list-type="simple">
<list-item>
<p>- Fasting caused (transient) inhibition of Pten in intestinal stem cells (<xref ref-type="bibr" rid="B44">44</xref>).</p>
</list-item>
<list-item>
<p>- Calorie restriction reduced expression of Pten in silkworm larvae (<xref ref-type="bibr" rid="B45">45</xref>).</p>
</list-item>
<list-item>
<p>- Maternal undernutrition reduced the expression of Pten in the liver of sheep offspring singletons (<xref ref-type="bibr" rid="B46">46</xref>).</p>
</list-item>
<list-item>
<p>- Offspring of mice with gestational diabetes mellitus have raised Pten expression; calorie restriction downregulated this (<xref ref-type="bibr" rid="B47">47</xref>).</p>
</list-item>
<list-item>
<p>- Pten was down regulated in fetal liver following a choline deficient, aminoacid defined (CDAA) diet in C57BL/6 mice (<xref ref-type="bibr" rid="B32">32</xref>).</p>
</list-item>
<list-item>
<p>- Maternal protein deprivation resulted in upregulation of PI3K and GLUT4 in muscles of the offspring of rats (consistent with Pten deficiency, though this was not specifically reported) and increased insulin sensitivity into adulthood (<xref ref-type="bibr" rid="B48">48</xref>).</p>
</list-item>
</list>
</list-item>
<list-item>
<p>Has altered PTEN expression been demonstrated in normal human tissue? Defining the “normal dose” of the protein is impractical as it varies across tissues; studies usually compare the expression of the PTEN protein to that of a protein from another gene (by immunohistochemistry). Not surprisingly, most reported studies are from cancer patients, where expression of PTEN in Tumor tissue has been compared to adjacent “normal tissue”(which may not necessarily be normal) (<xref ref-type="bibr" rid="B49">49</xref>). There are scattered studies reporting loss in adjacent normal tissue in cancers of breast (<xref ref-type="bibr" rid="B50">50</xref>), endometrium (<xref ref-type="bibr" rid="B51">51</xref>), gallbladder (<xref ref-type="bibr" rid="B52">52</xref>), colon (<xref ref-type="bibr" rid="B53">53</xref>), esophagus (<xref ref-type="bibr" rid="B54">54</xref>), thyroid (<xref ref-type="bibr" rid="B55">55</xref>), and kidney (<xref ref-type="bibr" rid="B56">56</xref>).</p>
</list-item>
</list>
<p>Interestingly, these are also obesity related cancers (ORCs), a point to which I will return to later. It is, of course, not known whether these individuals with loss in normal tissue were nutritionally deprived <italic>in utero</italic>.</p>
<p>Information about methylated PTEN in normal tissue is even scarcer (<xref ref-type="bibr" rid="B57">57</xref>–<xref ref-type="bibr" rid="B61">61</xref>). There are several caveats about promoter methylation and resultant repression of the gene that is worth keeping in mind (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>).</p>
<list list-type="simple">
<list-item>
<p>- Epigenetic change is not an “all or none” phenomenon—a promoter can be partially methylated in precursor lesions and then progress to full methylation and complete gene silencing. As noted earlier (<xref ref-type="bibr" rid="B18">18</xref>), subtle suppression of PTEN protein production is enough for carcinogenesis.</p>
</list-item>
<list-item>
<p>- Transcriptional silencing does not always require hypermethylation of the entire CpGisland, but methylation of a few specific core CpGdinucleotides may be sufficient.</p>
</list-item>
<list-item>
<p>- Methylation can occur outside the promoter region (long range epigenetic silencing).</p>
</list-item>
</list>
</sec>
<sec id="s5">
<title>Downregulation of PTEN Primes the Organism for Nutrition-Poor Environment</title>
<p>If PTEN is indeed the 30 gene, how will a downregulated PTEN prime the offspring for a nutrition poor environment? The ideal thrifty gene makes efficient use of available energy to grow and reproduce (<xref ref-type="bibr" rid="B64">64</xref>). The information we have about PTEN loss is based on knock out (KO) animal models (<xref ref-type="bibr" rid="B65">65</xref>); this leads to complete absence, and may not strictly conform to what occurs when there is more subtle reduction of PTEN expression, as envisioned in this theory.</p>
<list list-type="order">
<list-item>
<p>Loss of PTEN is associated with increased self-renewal, cell survival, and proliferation; this is seen in normal human embryonic stem cells (<xref ref-type="bibr" rid="B66">66</xref>), as well as cancer stem cells (<xref ref-type="bibr" rid="B67">67</xref>).</p>
</list-item>
<list-item>
<p>PTEN loss is associated with resistance to starvation, by improved energy efficiency and macropinocytosis (scavenging necrotic cell debris, proteins, and extracellular fluid). Pten mutant Drosophilia flies survived starvation better than Pten wild (<xref ref-type="bibr" rid="B68">68</xref>). Similarly, Pten mutant cells proliferate better under conditions of nutrition restriction (<xref ref-type="bibr" rid="B69">69</xref>); they switched from hypertrophic growth to hyperplastic growth in one study [though this is point is controversial with some studies showing Pten mutant cells are larger (<xref ref-type="bibr" rid="B70">70</xref>)]. Cancer cells deficient in PTEN are resistant to starvation, which is restored by replacing PTEN (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>).</p>
</list-item>
<list-item>
<p>PTEN deficient cells are more energy efficient. Overexpression of Pten, by introducing an extra Pten, caused these transgenic mice (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>) to display increased energy expenditure by activation of brown adipose tissue (BAT) via uncoupling protein 1 (UCP1). Over-expression of PTEN is clearly detrimental in a nutrient-poor environment, resulting in energy wastage. However, it is important to remember this property as insufficient PTEN expression will prevent the organism from “burning off” excess calories, which then has to be stored as fat. (The importance of burning off excess calories is discussed later under the section on “protein leverage.” PTEN inactivation bestowed a bioenergetic advantage to the cells by up-regulating mitochondrial respiratory capacity (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>). These cells upregulate oxidative phosphorylation and generate more ATP, wasting less energy in heat production. [However, cancer cells prefers aerobic glycolysis (Warburg effect), presumably to promote flux into biosynthetic pathways (<xref ref-type="bibr" rid="B77">77</xref>); despite frequent loss of PTEN].</p>
</list-item>
<list-item>
<p>PTEN loss permits safe storage of excess fat. Insulin is primarily a fat storage hormone and higher levels of insulin is a postulated reason for obesity (as per the carbohydrate-insulin model of obesity).“Safe” here means storage without inducing insulin resistance. This is best seen in Cowden syndrome that occurs due to germline mutation of PTEN where insulin sensitivity is maintained despite obesity (<xref ref-type="bibr" rid="B78">78</xref>). PTEN loss in sporadic mutations also leads to obesity with retained insulin sensitivity (<xref ref-type="bibr" rid="B79">79</xref>), which is consistent with its position downstream of the insulin pathway, inhibiting PI3K/AKT/mTOR pathway. Loss of PTEN has a “brake-off” effect on this pathway, with unrestricted flow of signals at lower serum insulin levels. The major impact of any gene on thriftiness would be modulation of the insulin pathway proportional to availability of nutrition (<xref ref-type="bibr" rid="B64">64</xref>), and PTEN fits this role. Women have higher insulin sensitivity despite higher fat mass, apparently due to downregulation of PTEN gene expression in skeletal muscle; however, here the PTEN inactivation is possibly by phosphorylation (<xref ref-type="bibr" rid="B80">80</xref>). Incidentally, PTEN deficient preadipocytes derived from lipomas seen in PTEN mutant children have been noted to have increased fat storage (and proliferative) capacity (<xref ref-type="bibr" rid="B81">81</xref>); this can be suppressed by inhibitors of mTOR (everolimus) or PI3K (alpelisib) (<xref ref-type="bibr" rid="B82">82</xref>). Pten haploinsufficient mice, when given high calorie diet, had lower insulin (and glucose) levels but put on same overall and visceral weight as their wild counterparts (suggesting higher efficiency of the metabolic pathway), with similar increase in cholesterol and triglyceride (<xref ref-type="bibr" rid="B83">83</xref>).</p>
</list-item>
<list-item>
<p>PTEN deficiency leads to smaller size offspring. As noted by Prentice et al. (<xref ref-type="bibr" rid="B2">2</xref>), chronic food shortages end up creating a smaller mother, which imposes a “maternal uterine constraint” on the size of the fetus. Obviously, having a large baby poses serious health risks to the malnourished mother. In mouse models, partial PTEN deletion in the hypothalamus resulted in whole body growth restriction (<xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B85">85</xref>). However, this is not universal finding; other studies have reported Pten deficient mice cannot be “physically distinguished” from their litter mates (<xref ref-type="bibr" rid="B86">86</xref>).</p>
</list-item>
<list-item>
<p>Pten deficiency induces Behavioral changes including hyperphagia (<xref ref-type="bibr" rid="B87">87</xref>); it reduces muscle protein degradation (<xref ref-type="bibr" rid="B88">88</xref>) and improves endurance (<xref ref-type="bibr" rid="B89">89</xref>), both presumably contributing to a survival benefit in a harsh environment. PTEN alteration can also possibly influence Behavior, as loss of PTEN function is implicated in Behavioral disorders such as autism (<xref ref-type="bibr" rid="B90">90</xref>).</p>
</list-item>
<list-item>
<p>PTEN deficiency in murine oocytes causes the entire oocyte pool to become activated prematurely; this has the effect of females having a maximum of one normal-sized litter before they became infertile at 12–13 weeks of age (<xref ref-type="bibr" rid="B91">91</xref>). In nutrition constrained environment, limiting the number of offspring and reducing competition could have its own evolutionary advantages. However, in another study but in adult mice, low protein diet given ad libitum resulted in increased expression of Pten in oocytes and delayed the activation of ovarian primordial follicles (<xref ref-type="bibr" rid="B92">92</xref>).</p>
</list-item>
<list-item>
<p>Another evolutionary benefit is a shortened lifespan seen in Pten deficient mice, partly attributable to a higher incidence of cancer (<xref ref-type="bibr" rid="B93">93</xref>). PTEN can be thought to set the level of “energy entitlement” at conception; the upper limit of what the offspring is eligible to consume through its life in that particular degree of nutrition availability. Consuming more than entitlement is potentially detrimental to other members of the society; in this sense, it can be thought of as a “self-destruct button”.</p>
</list-item>
</list>
<p>In summary (<xref ref-type="table" rid="T1">Table 1</xref>), subtle dose reduction of PTEN proportional to the degree of nutritional deprivation can modify the organism to adapt to a nutrition-poor environment by improving energy efficiency, safe storage of excess energy as fat, and early reproduction. However, this also results in restricted ability to burn off excess calories, resulting in obesity, and its consequences.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Potential benefits of reduced PTEN expression.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>SR No</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Benefit</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Improved cell proliferation and survival</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Resistance to starvation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Energy efficiency</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Efficient storage of excess fat</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Smaller offspring</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered behavior (hyperphagia)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Early fertility</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced life span (quicker turn over)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s6">
<title>Downregulated PTEN Results in Diseases in Nutrient-Rich Environment</title>
<p>The key reason why we are currently concerned with identification of thrifty genes is their postulated role in human disease in a discordant, nutrient-rich environment. The ability of a thrifty gene to reduce energy expenditure and store fat, has distinct survival benefits in a nutrient-poor environment However, excess fat storage can lead to obesity. Fat stored in ectopic locations leads to insulin resistance (IR) and metabolic disorders (type 2 diabetes mellitus, dyslipidemia, cardiovascular diseases) and obesity related cancers (ORCs) in an obesogenic environment. Whether hyperinsulinemia, a marker of IR, is the cause or effect of obesity is still a matter of debate (<xref ref-type="bibr" rid="B94">94</xref>).</p>
<p>It has been proposed that the thrifty gene should have the property of plasticity to adapt to a nutrient-rich environment (<xref ref-type="bibr" rid="B2">2</xref>) but I believe that it is the inability to adapt that leads to disease.</p>
<sec>
<title>PTEN, Obesity and Insulin Resistance</title>
<p>The relationship between obesity, IR and metabolic syndrome is still a matter of discussion and controversy; the two leading hypothesis being the conventional “calorie imbalance (calorie in; calorie out) model” and the more recent “carbohydrate-insulin model.” Whether hyperinsulinemia, a marker of IR, is the cause or effect, is also debated (<xref ref-type="bibr" rid="B95">95</xref>). Until this is settled, the role played by PTEN will remain a matter of speculation. It is obvious that PTEN deficiency as proposed in this paper is not compatible with insulin resistance, as PTEN loss is consistently associated with insulin sensitivity [retained even in obese patients of PTEN mutations such as Cowden syndrome (<xref ref-type="bibr" rid="B78">78</xref>)].</p>
<p>It is important to understand that fat storage leading to obesity is not <italic>sine qua non</italic> for insulin resistance (IR). It is generally accepted that it is the location, rather than the amount of stored fat that determines IR. Current dogma suggests that IR is due to ectopic fat deposition (<xref ref-type="bibr" rid="B96">96</xref>) in locations such as liver [intrahepatic lipids (IHL)], muscles [intramyocellular lipid (IMCL)] or visceral adipose tissue (VAT). Storage in subcutaneous fat (SAT) is considered benign. Liver specific deletion of Pten causes NAFLD (a form of IHL), but these mice remain insulin sensitive and have an overall reduction in body fat (<xref ref-type="bibr" rid="B97">97</xref>). This is consistent with the possibility that higher insulin sensitivity in Pten deficient hepatocytes drives glucose into liver cells, increases de no lipogenesis (DNL) and results in fatty liver; presumably peripheral fat is preferentially drawn in and stored in liver.</p>
<p>Similarly, deletion of Pten in adipose tissue (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B98">98</xref>), skeletal muscle cells (<xref ref-type="bibr" rid="B99">99</xref>), pancreatic beta cells (<xref ref-type="bibr" rid="B100">100</xref>), or neurons expressing Cre (<xref ref-type="bibr" rid="B101">101</xref>) results in insulin sensitivity, despite massive deposits of fat in SAT after high fat diet (HFD) as seen in the last model. Systemic inhibition of Pten in diabetic mice using antisense oligonucleotide resulted in downregulation of Pten in liver (by 90%) and fat (by 75%), reduced insulin levels and restored insulin sensitivity (<xref ref-type="bibr" rid="B102">102</xref>).</p>
<p>It is interesting to speculate that PTEN could have a role in body fat distribution and lay the foundations of a metabolically unhealthy organism (such as reduced capacity in subcutaneous adipose tissue forcing storage in the unhealthy visceral adipose tissue); however, the data available is not sufficient to support such a possibility. Deletion of Pten in a subset of adipocytes leads to redistribution of body fat with lipomatosis and partial lipodystrophy (<xref ref-type="bibr" rid="B103">103</xref>); however, the changes were not specific to SAT vs. VAT pattern.</p>
<p>Organ of involvement: Does downregulation of PTEN occur in all body tissues or in specific organs (such as liver, muscles or fat)? Downregulation in adipose tissue can explain most of the features of metabolic syndrome. AiPKO mice (<xref ref-type="bibr" rid="B39">39</xref>), where Pten was deleted in mature adipocytes, maintained insulin sensitivity despite putting on (mainly)SAT on high fat diet; knocking out Pten after HFD-induced weight gain restored insulin sensitivity and reduced hepatic steatosis.</p>
<p>In a more recent study (<xref ref-type="bibr" rid="B104">104</xref>), fat depot specific deletion of Pten induced expansion of local fat depots, with upregulation of Pten in other depots and reduced fat mass there (analogs to deletion of Pten in liver resulting in fatty liver); this is thought to work through an “adipose PTEN—leptin—sympathetic nervous system” activation pathway. The authors suggest that the compensatory upregulation of PTEN in other adipose tissues suggests a “homeostatic set point of PTEN” and the “adipose PTEN-leptin—SNS—PTEN” loop contributes to the maintenance of whole-body adiposity and adipose distribution in adult animals.”</p>
<p>It is tempting to suggest that PTEN downregulation in nutrionally stressed organism occurs preferentially in subcutaneous adipose tissue (SAT), priming the organism for safe fat storage. Evolutionarily, SAT has been the organ around which the “fasting vs. feasting” revolves. As the study by Huang et al. (<xref ref-type="bibr" rid="B104">104</xref>) indicates, when this storage capacity is overcome, ectopic fat storage results (<xref ref-type="bibr" rid="B96">96</xref>); this is thought that excessive fat storage leads to distension of adipocytes of SAT, activation of adipose triglyceride lipase (ATGL) enzyme, leak of FFA into blood and uptake in other tissues, leading to IR and metabolic syndrome. However, to explain other facets of the thrifty gene hypothesis, such as altered reproduction and increased susceptibility to cancer, deficiency of PTEN in other tissues is essential.</p>
<p>Interestingly, new born Indian babies, though lighter, have increased fat storage (“thin-fat babies”) and this has been correlated with increased risk of metabolic syndrome in adulthood (<xref ref-type="bibr" rid="B105">105</xref>). Although the PTEN values in these babies are unknown, the insulin levels are equivalent to a comparable cohort born in London, suggesting greater efficiency of the metabolic pathway (<xref ref-type="bibr" rid="B106">106</xref>). (The authors have tried to prove hyperinsulinemia in the Indian babies by adjusting insulin levels to the birth weight, but the serum values (which are more relevant) are not statistically different. The level of clinically relevant glucose value, for example, is “per 100 ml serum,” not “100 ml serum adjusted to body weight”). The authors have suggested that vitamin B12 deficiency and 1-carbon chain abnormalities could result in this thrifty phenotype and has led to the current DM epidemic in India (<xref ref-type="bibr" rid="B107">107</xref>). Experimentally, increasing folate levels in breast cancer cell lines lead to increased DNMT1 levels, with promoter methylation of PTEN and its downregulation (and cancer progression) (<xref ref-type="bibr" rid="B108">108</xref>). Since pregnant women in India are routinely supplemented with folate (and iron) to prevent neural tube defects, this could be an aggravating factor for the T2DM epidemic in India. In the Pune cohort referred to above, higher maternal erythrocyte folate concentrations at 28 weeks predicted higher offspring adiposity and IR at 6 years of age (<xref ref-type="bibr" rid="B109">109</xref>).</p>
<p>Americans have higher rates of T2DM than Europeans (<xref ref-type="bibr" rid="B110">110</xref>); Americans also suffer from more side effects of an oral chemotherapy drug called capecitabine. The latter has been linked to higher folate levels in Americans (<xref ref-type="bibr" rid="B111">111</xref>) due to food fortification; further investigations are warranted in the relation between folate, PTEN and T2DM.</p>
<p>The relationship between PTEN and insulin sensitivity has been demonstrated in other studies. A Korean study reported that the commonly used oral hypoglycemic agent, metformin, downregulates PTEN via AMPK in preadipocytes and sensitizes them to insulin (<xref ref-type="bibr" rid="B112">112</xref>).</p>
<p>Liver specific knock out of Pten in mice lead to fatty liver with maintained insulin sensitivity (<xref ref-type="bibr" rid="B100">100</xref>). Obese Zucker Diabetic Fatty (ZDF) rats that display all features of IR and metabolic syndrome (high glucose, insulin, triglycerides and fatty liver) had reduced PTEN expression (mRNA) (by around 40%) in the liver; the same was found in liver of obese humans (<xref ref-type="bibr" rid="B38">38</xref>). This study also suggested that unsaturated fatty acids downregulated Pten, which then lead to upregulation of free fatty acid (FFA) transporter CD36 and increased synthesis of triglycerides (setting up a vicious cycle). [Another study by the same team suggested that liver PTEN was downregulated by FFA via micro-RNA-21(<xref ref-type="bibr" rid="B113">113</xref>)]. In conclusion, PTEN insufficiency leads to fatty liver (whether by liver specific knockout, where systemic insulin sensitivity is maintained as fat preferentially accumulates in liver; or by obesity <italic>per se</italic>, where excess FFA released by overloaded adipocytes of SAT can downregulate PTEN in liver via FFA; this of course, will be associated with insulin resistance). An organism born with PTEN insufficiency is thus prone to fatty liver, a major component of metabolic syndrome.</p>
<p>It may appear paradoxical but one study showed higher levels (more than 3 fold) of Pten mRNA and protein in skeletal muscle of obese Zucker rats (<xref ref-type="bibr" rid="B114">114</xref>), and lean Zucker rats showed upregulation of Pten (2 fold) on high fructose diet in the face of systemic insulin resistance. However, this PTEN upregulation can be interpreted as being protective for the muscle against glucotoxicity and lipotoxicity by dampening down the metabolic pathway. Although there is higher intramyocyte fat content in these obese individuals, there is no equivalent pathological “fatty muscle disease.”</p>
<p>The status of PTEN in humans in relation to obesity and Type 2 diabetes mellitus (T2DM) has not been studied well (<xref ref-type="bibr" rid="B115">115</xref>) and the reported data is patchy; for instance:</p>
<list list-type="simple">
<list-item>
<p>- A bioinformatics analysis of the search for the CpG islands in the promoter regions of obesity-related genes has identified PTEN as being hypermethylated (<xref ref-type="bibr" rid="B116">116</xref>) (downregulation).</p>
</list-item>
<list-item>
<p>- A study from Iran (<xref ref-type="bibr" rid="B117">117</xref>) showed that patients with metabolic syndrome were more likely to have methylated PTEN than normal people (downregulation).</p>
</list-item>
<list-item>
<p>- PTEN mRNA is overexpressed in omental tissue (which is considered as VAT) in obese patients with endometrial carcinoma [Table 3, refer Berstein et al. (<xref ref-type="bibr" rid="B118">118</xref>)].</p>
</list-item>
<list-item>
<p>- A study on Uyghur Muslims (<xref ref-type="bibr" rid="B61">61</xref>) showed lower promoter methylation of PTEN in T2DM patients as compared to normal (3.27 vs. 7.28%), leading to PTEN overexpression.</p>
</list-item>
<list-item>
<p>- A PTEN-polymorphism that results in higher expression of PTEN showed significant correlation with T2DM in Japanese (<xref ref-type="bibr" rid="B119">119</xref>), marginal with Chinese Han (<xref ref-type="bibr" rid="B120">120</xref>) and none in Danish population (<xref ref-type="bibr" rid="B121">121</xref>). This is not an epigenetic change but is included to indicate of how conflicting the data is.</p>
</list-item>
</list>
<p>Obviously, the maternal nutrition or intrauterine history of the subjects in the above studies is not known.</p>
<p>Downregulation of PTEN represses the ability of body to burn of excess calories. The ability to burn off excess calories is crucial, because, as per the “protein leverage theory,” organisms will continue to ingest food till a certain level of proteins (especially methionine) is acquired (<xref ref-type="bibr" rid="B21">21</xref>). In this obesogenic environment with excess of carbohydrates, getting adequate proteins would mean ingesting large amounts of calories. Inability to burn them would leave the only option of storage, which would be facilitated by an adapted PTEN.</p>
<p>In summary, underexpression of PTEN would promote fat storage due to a more efficient insulin-PI3K/AKT/mTOR pathway, and an inability to burn of excess calories. The reasons for progression to IR must remain speculative. PTEN is certainly not the sole factor determining insulin response. It is possible the PTEN remains underexpressed and is bypassed/ overcome in creation of IR in a nutrient-rich environment. Hyperinsulinemia, which accompanies IR, could be the cause, rather than the effect of obesity (<xref ref-type="bibr" rid="B94">94</xref>). The possibility that hyperinsulinemia (present in small for date infants) is needed for growth, and IR is the body's response to protect muscles from glucotoxicity has been discussed by Wells (<xref ref-type="bibr" rid="B64">64</xref>). Interestingly, PTEN positive and negative cells proliferate similarly up to a certain level of glucose, but PTEN deficient cells start proliferating rapidly at higher levels (<xref ref-type="bibr" rid="B122">122</xref>). Insulin levels rise in response to higher levels of dietary glucose, leading to storage of excess energy as fat (acceptable in adipose tissue) but could lead to a proliferative response in other cells (such as in PTEN deficient); this is detrimental to the organism and IR (by whichever mechanism) could be a protective response by the body to prevent tissues from reacting to high proximate glucose (<xref ref-type="bibr" rid="B123">123</xref>). Multiple mechanisms, mostly PTEN-independent, has been postulated as cause of IR; one such is the secretion of Galectin-3 protein by macrophages infiltrating the adipose tissue, which binds directly to insulin receptor and causes IR (<xref ref-type="bibr" rid="B124">124</xref>). Fetuin-A, secreted from liver and adipose tissue, can also result impair insulin signaling (<xref ref-type="bibr" rid="B125">125</xref>).</p>
<p>It is theoretically possible that the offspring born with low “dose” of PTEN, when faced with a nutrition rich environment, upregulates PTEN, leading to IR and its ill effects. This would imply plasticity of the gene, which is against the basic premise of this hypothesis; obesity related diseases results from a fixed metabolic capacity at birth, and an inability to adapt. PTEN can be upregulated in obesity to create IR via free fatty acids (FFA) (<xref ref-type="bibr" rid="B126">126</xref>) and several pro-inflammatory cytokines such as Tumor Necrosis Factor alpha (TNFα) (<xref ref-type="bibr" rid="B127">127</xref>) and resisting (<xref ref-type="bibr" rid="B128">128</xref>, <xref ref-type="bibr" rid="B129">129</xref>).</p>
<p>The only study aimed at finding PTEN level in relation to maternal diet comes from the laboratory of Dr. Susan Ozanne and has been referred to earlier (<xref ref-type="bibr" rid="B25">25</xref>). A maternal low protein diet resulted in increased mammary tumorigenesis in the offspring, with underexpression of PTEN in tumor tissue. A highly palatable diet post weaning induced weight gain but did not increase PTEN in the tumor tissue of the low protein group significantly. Unfortunately, the status of Pten in normal tissue was not reported.</p>
</sec>
<sec>
<title>PTEN and Cancer</title>
<p>The data regarding the role of PTEN in cancer is abundant and reviewed (<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B131">131</xref>) and is consistent; PTEN insufficiency increases cancer susceptibility. This is not surprising as PTEN was initially identified as a Tumor suppressor gene. Reduced “dose” of PTEN increases PIP3 and activates the proliferative PI3K/AKT/mTOR pathway (<xref ref-type="bibr" rid="B18">18</xref>). Deficiency of PTEN has been recorded in multiple cancers and Pten knock out animals are good models for tumorigenesis (<xref ref-type="bibr" rid="B132">132</xref>). As noted earlier (<xref ref-type="bibr" rid="B50">50</xref>), PTEN loss can be seen in adjacent “normal” tissue as well. PTEN expression can be lost due to multiple reasons but methylation leading to repression has been reported in cancers of endometrium (<xref ref-type="bibr" rid="B62">62</xref>), gallbladder (<xref ref-type="bibr" rid="B52">52</xref>), colon (<xref ref-type="bibr" rid="B53">53</xref>), prostate (<xref ref-type="bibr" rid="B133">133</xref>), and breast (<xref ref-type="bibr" rid="B134">134</xref>).</p>
<p>Studies also show that PTEN deficient animals develop more cancers when exposed to high fat diet, such as of prostate (<xref ref-type="bibr" rid="B135">135</xref>) and endometrium (<xref ref-type="bibr" rid="B136">136</xref>). Interestingly, most PTEN related cancers are also ORCs (<xref ref-type="bibr" rid="B137">137</xref>). Correlation between ORCs and PTEN deficiency in light of the thrifty gene theory suffers from lack of data about <italic>in utero</italic> influences or even weight of the patients. One study on endometrioid endometrial cancer (which is strongly correlated with obesity) showed “increased AMPK phosphorylation and IGFBP2 expression were observed in obese patients with PTEN loss. These findings are markers of nutrient deprivation, which is unexpected in the context of obesity”(<xref ref-type="bibr" rid="B138">138</xref>).</p>
<p>PTEN deficiency leads to hyperproliferation and probably plays a permissive role in carcinogenesis; additional events, usually in form of second mutation [e.g., in MYC (<xref ref-type="bibr" rid="B139">139</xref>) gene], is needed for malignant transformation—this is possible even in the absence of obesity. In the context of obesity, there are other postulated mechanisms. The role of fibroblast growth factors (FGF) and their receptors (FGFR) is especially compelling. It has been shown that visceral adipose tissue (VAT) produces FGF2 (<xref ref-type="bibr" rid="B140">140</xref>) which acts on FGFR to induce transformation of epithelial tissue; interactions involving PTEN in breast (<xref ref-type="bibr" rid="B141">141</xref>), endometrial (<xref ref-type="bibr" rid="B142">142</xref>), and prostate (<xref ref-type="bibr" rid="B143">143</xref>) cancers have been reported but exact nature of these interactions await further clarification.</p>
<p>Interestingly, feeding HFD to female mouse mammary tumor virus-Wnt-1 transgenic (Tg) mice resulted in higher incidence of breast cancers in their offspring; this was associated with downregulation of Pten (<xref ref-type="bibr" rid="B144">144</xref>). Similarly, in another mouse study, HFD in dams produced Pten-inactivated prostatic proliferation in the offspring (<xref ref-type="bibr" rid="B145">145</xref>). Thus, PTEN deficient cells can turn cancerous when exposed to HFD.</p>
</sec>
<sec>
<title>PTEN and PCOS</title>
<p>Nutrition (lack and excess) has significant effect on reproductive functions (<xref ref-type="bibr" rid="B146">146</xref>) and the metabolic syndrome equivalent in the reproductive system is polycystic ovary syndrome (PCOS); these two syndromes tend to overlap (<xref ref-type="bibr" rid="B147">147</xref>). It has been suggested that PCOS is likely a result of interactions between genetic predispositions and the modern obesogenic environment (<xref ref-type="bibr" rid="B148">148</xref>). Components of this syndrome include obesity, hyperandrogenism, polycystic ovaries, and anovulation (<xref ref-type="bibr" rid="B149">149</xref>). The exact cause of this syndrome is still not fully understood.</p>
<p>The role of PTEN in the ovary is pleiotropic and appears to be cell dependent. Essentially, the ovarian follicle has three types of cells—the oocyte, the granulosa cells and the covering theca cells.</p>
<list list-type="simple">
<list-item>
<p>a. As seen earlier (<xref ref-type="bibr" rid="B91">91</xref>), Pten deletion in primordial follicle lead to premature activation of oocytes and early infertility. However, a chronic low protein diet actually lead to upregulation of Pten in primordial ovarian follicle (via FGF21 and adiponectin) (<xref ref-type="bibr" rid="B92">92</xref>) with preservation of fertility; this was in adult mice; the effect of maternal low protein diet on Pten has not been studied (<xref ref-type="bibr" rid="B150">150</xref>).</p>
</list-item>
<list-item>
<p>b. In granulosa cells of PCOS patients, PTEN expression was reported as reduced (<xref ref-type="bibr" rid="B151">151</xref>) but in another study, insulin was shown to upregulate PTEN in granulosa cells (<xref ref-type="bibr" rid="B152">152</xref>). In another study, disruption of Pten in granulosa cells was associated with improved fertility (<xref ref-type="bibr" rid="B153">153</xref>).</p>
</list-item>
<list-item>
<p>c. In theca-interstitial cells, Pten deletion produced features of PCOS including hyperandrogenism and early fertility loss (<xref ref-type="bibr" rid="B154">154</xref>). Animal models suggest that the PI3K/AKT pathway plays a significant role in the molecular pathology of PCOS (<xref ref-type="bibr" rid="B155">155</xref>); the outcome of Pten deletion in theca cells is consistent with this. The involvement of PI3K pathway in PCOS is further demonstrated by the fact that PTEN expression is altered in endometrium of PCOS patients (<xref ref-type="bibr" rid="B156">156</xref>).</p>
</list-item>
</list>
<p>It would appear that, just in case of cancer, downregulation of PTEN in specific cells of ovary creates a permissive background for PCOS, which is precipitated by a high-nutrition environment. It, of course, remains to be demonstrated that maternal protein restriction results in PTEN downregulation in the ovary, especially the theca cells. Curiously, NAFLD is another condition with PTEN downregulation (in hepatocytes)which is associated with peripheral insulin resistance (<xref ref-type="bibr" rid="B38">38</xref>), and both PCOS and NAFLD tend to overlap—in fact, about 40% of the PCOS patients have NAFLD (<xref ref-type="bibr" rid="B157">157</xref>). Metformin, which is used with some success in both conditions, is an AMPK activator which induces PTEN (<xref ref-type="bibr" rid="B158">158</xref>).</p>
</sec>
</sec>
<sec id="s7">
<title>Differential Expression of PTEN Explains Lack of Consistency in Data</title>
<p>The data regarding PTEN and maternal nutrition, as collated in this paper, is not and cannot be consistent as it would vary depending on experimental conditions. However, it is known that gene expression varies among tissue and it is likely that PTEN expression is not uniformly suppressed across major tissue types (brain, liver, adipose tissue, and muscles) in response to nutritional constraint. Pten haploinsufficient or KO mice are not appropriate models to decide this and unfortunately, there is no low protein (LP) or maternal methionine-choline deficient (MCD) diet models where Pten has been analyzed across different tissues. There is indirect evidence to suggest PTEN expression can be variable. For instance, analysis of metabolically stressed <italic>in vitro</italic> fertilized mice showed acetylation of Txnip gene (involved in metabolism); the adult mice had upregulated mRNA and protein expression of the Txnip as compared to controls (<xref ref-type="bibr" rid="B159">159</xref>). But there was differential expression in the tissues—with increased expression of Txnip RNA and protein in adult fat and muscle but not liver or pancreas. TXNIP can activate PTEN by reduction; interestingly, in Txnip KO mice, Pten is inactive in oxidative tissue (skeletal muscle and hearts) but not in lipogenic tissues (liver and adipose tissue) (<xref ref-type="bibr" rid="B160">160</xref>). Similarly, in a porcine model (<xref ref-type="bibr" rid="B29">29</xref>), low protein diet reduced levels of Dnmt1 and 3b in fetal liver while increasing expression of 3a; but in fetal muscle, Dnmt3a was reduced, Dnmt1 increased with no change in 3b. Target genes were altered and the authors suggest that the “differential DNMT3a and DNMT3b gene expression (in liver and muscle) implicates a tissue-specific impact of maternal diet on both fetal liver and muscle tissue” (<xref ref-type="bibr" rid="B29">29</xref>). It would appear that <italic>in utero</italic> epigenetic modifications do not uniformly affect diverse tissues. There could be differential expression depending on various factors such as the availability of redox mechanisms.</p>
</sec>
<sec id="s8">
<title>Proving the Hypothesis</title>
<p>There are enough gene expression and methylome profiles existing of both human and animal models of nutrition deprivation that can be analyzed for PTEN expression; the difficulty would be in defining the normal expression since there is no “on” or “off” level, only degrees of activity. It would be particularly interesting to see the Pten levels in normal tissue of the low protein model (<xref ref-type="bibr" rid="B25">25</xref>) generated in Dr. Ozanne's laboratory. Experimentally, this can be proven by analyzing PTEN levels in offspring of animals deprived of specific nutrients, especially in organs of interest such as adipose tissue, liver and muscles, and confirming that these changes were brought about by via the methylation arm of the epigenetic pathway. Additional generations can be analyzed to look for transgenerational inheritance.</p>
</sec>
<sec id="s9">
<title>Conclusions (<xref ref-type="fig" rid="F1">Figure 1</xref>)</title>
<p>It is proposed that PTEN is the primary thrifty gene (<xref ref-type="table" rid="T2">Table 2</xref>). Epigenetic modification (methylation) of PTEN promoter suppresses the expression of the gene proportional to availability of nutrients (protein, and possibly choline). This sets the metabolic capacity and adapts the fetus to nutrition availability in post natal environment. A mismatch with calorie abundance results in efficient storage and limited expenditure and causes obesity, metabolic syndrome and cancer. The crux of a thrifty gene is its ability to efficiently use limited energy for growth and reproduction, and store the excess safely, and multiple lines of evidence suggest that PTEN does this brilliantly.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Deficiency of nutrients <italic>in utero</italic>, specifically proteins and choline lead to upregulation of DNMT3a and possibly 1, resulting in promoter methylation and suppression of PTEN, to varying degrees. This adapts the offspring to a nutritionally constrained post natal environment with efficient fat storage and reduced thermogenesis. If the birth environment continues to lack nutrition, the organism is well-adapted for survival, but in an obesogenic environment, would result in obesity, metabolic disorders, and cancer.</p>
</caption>
<graphic xlink:href="fnut-07-00081-g0001"></graphic>
</fig>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Summary of evidence supporting the hypothesis.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Postulate</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Evidence</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>CAUSE: LOW PTEN DUE TO:</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. Specific nutritional deficiency reduces PTEN expression in tissues &amp; offspring</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Experimental data with low protein, methionine and choline diets.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B46">46</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.This effect is through epigenetic pathway</td>
<td align="left" colspan="1" rowspan="1" valign="top">Experimental data shows upregulation of DNMT3a.</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B31">31</xref>)</td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>EFFECT: LOW PTEN CAN LEAD TO:</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. Obesity</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Seen in Cowden syndrome.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B78">78</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">HFD causes obesity with PTEN deleted models.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B101">101</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hypermethylated (downregulated) PTEN is associated with metabolic syndrome.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B116">116</xref>, <xref ref-type="bibr" rid="B117">117</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. Fatty liver (NAFLD)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Liver specific deletion causes fatty liver.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B97">97</xref>, <xref ref-type="bibr" rid="B100">100</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.Cancer</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Tumor suppressor gene.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B131">131</xref>)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Low expression in multiple obesity related cancers (ORCs).</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">(<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B133">133</xref>, <xref ref-type="bibr" rid="B134">134</xref>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">4.PCOS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deletion in theca-interstitial cells leads to features of PCOS.</td>
<td align="left" colspan="1" rowspan="1" valign="top">(<xref ref-type="bibr" rid="B154">154</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s10">
<title>Author Contributions</title>
<p>The author confirms being the sole contributor of this work and has approved it for publication.</p>
</sec>
<sec id="s11">
<title>Conflict of Interest</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neel</surname><given-names>JV</given-names></name></person-group>. <article-title>Diabetes mellitus: a thrifty genotype rendered detrimental by progress?</article-title>
<source/>Am J Hum Genet. (<year>1962</year>) <volume>14</volume>:<fpage>353</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">13937884</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prentice</surname><given-names>AM</given-names></name><name><surname>Rayco-Solon</surname><given-names>P</given-names></name><name><surname>Moore</surname><given-names>SE</given-names></name></person-group>. <article-title>Insights from the developing world: thrifty genotypes and thrifty phenotypes</article-title>. <source/>Proc Nutr Soc. (<year>2005</year>) <volume>64</volume>:<fpage>153</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1079/PNS2005421</pub-id><pub-id pub-id-type="pmid">15960860</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speakman</surname><given-names>JR</given-names></name></person-group>. <article-title>Thrifty genes for obesity and the metabolic syndrome — time to call off the search?</article-title>
<source/>Diabetes Vasc Dis Res. (<year>2006</year>) <volume>3</volume>:<fpage>7</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.3132/dvdr.2006.010</pub-id><pub-id pub-id-type="pmid">16784175</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>CN</given-names></name><name><surname>Barker</surname><given-names>DJP</given-names></name></person-group>. <article-title>Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis</article-title>. <source/>Diabetologia. (<year>1992</year>) <volume>35</volume>:<fpage>595</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1007/BF00400248</pub-id><pub-id pub-id-type="pmid">1644236</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gluckman</surname><given-names>PD</given-names></name><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Buklijas</surname><given-names>T</given-names></name></person-group>. <article-title>A conceptual framework for the developmental origins of health and disease</article-title>. <source/>J Dev Orig Health Dis. (<year>2009</year>) <volume>1</volume>:<fpage>6</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1017/S2040174409990171</pub-id><pub-id pub-id-type="pmid">25142928</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>TP</given-names></name><name><surname>Watkins</surname><given-names>AJ</given-names></name><name><surname>Velazquez</surname><given-names>MA</given-names></name><name><surname>Mathers</surname><given-names>JC</given-names></name><name><surname>Prentice</surname><given-names>AM</given-names></name><name><surname>Stephenson</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Origins of lifetime health around the time of conception: causes and consequences</article-title>. <source/>Lancet. (<year>2018</year>) <volume>391</volume>:<fpage>1842</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)30312-X</pub-id><pub-id pub-id-type="pmid">29673874</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianco-Miotto</surname><given-names>T</given-names></name><name><surname>Craig</surname><given-names>JM</given-names></name><name><surname>Gasser</surname><given-names>YP</given-names></name><name><surname>van Dijk</surname><given-names>SJ</given-names></name><name><surname>Ozanne</surname><given-names>SE</given-names></name></person-group>. <article-title>Epigenetics and DOHaD: from basics to birth and beyond</article-title>. <source/>J Dev Orig Health Dis. (<year>2017</year>) <volume>8</volume>:<fpage>513</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1017/S2040174417000733</pub-id><pub-id pub-id-type="pmid">28889823</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stöger</surname><given-names>R</given-names></name></person-group>. <article-title>The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes?</article-title>
<source/>BioEssays. (<year>2008</year>) <volume>30</volume>:<fpage>156</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1002/bies.20700</pub-id><pub-id pub-id-type="pmid">18197594</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>DS</given-names></name><name><surname>Ebbeling</surname><given-names>CB</given-names></name></person-group>. <article-title>The carbohydrate-insulin model of obesity: beyond calories in, calories out</article-title>. <source/>JAMA Intern Med. (<year>2018</year>) <volume>178</volume>:<fpage>1098</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1001/jamainternmed.2018.2933</pub-id><pub-id pub-id-type="pmid">29971406</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taubes</surname><given-names>G</given-names></name></person-group>. <article-title>The science of obesity: what do we really know about what makes us fat? an essay by Gary Taubes</article-title>. <source/>BMJ. (<year>2013</year>) <volume>346</volume>:<fpage>f1050</fpage>. <pub-id pub-id-type="doi">10.1136/bmj.f1050</pub-id><pub-id pub-id-type="pmid">23596125</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corkey</surname><given-names>BE</given-names></name></person-group>. <article-title>Diabetes: have we got it all wrong?</article-title> Insulin hypersecretion and food additives: cause of obesity and diabetes? <source/>Diabetes Care. (<year>2012</year>) <volume>35</volume>:<fpage>2432</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2337/dc12-0825</pub-id><pub-id pub-id-type="pmid">23173132</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lustig</surname><given-names>RH</given-names></name></person-group>. <article-title>Fructose and nonalcoholic fatty liver disease</article-title>. <source/>J Calif Dent Assoc. (<year>2016</year>) <volume>44</volume>:<fpage>613</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">29035477</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YR</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>The functions and regulation of the PTEN tumour suppressor: new modes and prospects</article-title>. <source/>Nat Rev Mol Cell Biol. (<year>2018</year>) <volume>19</volume>:<fpage>547</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-018-0015-0</pub-id><pub-id pub-id-type="pmid">29858604</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>MS</given-names></name><name><surname>Salmena</surname><given-names>L</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>The functions and regulation of the PTEN tumour suppressor</article-title>. <source/>Nat Rev Mol Cell Biol. (<year>2012</year>) <volume>13</volume>:<fpage>283</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3330</pub-id><pub-id pub-id-type="pmid">22473468</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmena</surname><given-names>L</given-names></name><name><surname>Carracedo</surname><given-names>A</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>Tenets of PTEN tumor suppression</article-title>. <source/>Cell. (<year>2008</year>) <volume>133</volume>:<fpage>403</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.04.013</pub-id><pub-id pub-id-type="pmid">18455982</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotman</surname><given-names>LC</given-names></name><name><surname>Niki</surname><given-names>M</given-names></name><name><surname>Dotan</surname><given-names>ZA</given-names></name><name><surname>Koutcher</surname><given-names>JA</given-names></name><name><surname>Di Cristofano</surname><given-names>A</given-names></name><name><surname>Xiao</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Pten dose dictates cancer progression in the prostate</article-title>. <source/>PLoS Biol. (<year>2003</year>) <volume>1</volume>:<fpage>e59</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0000059</pub-id><pub-id pub-id-type="pmid">14691534</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carracedo</surname><given-names>A</given-names></name><name><surname>Alimonti</surname><given-names>A</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>PTEN level in tumor suppression: how much is too little?</article-title>
<source/>Cancer Res. (<year>2011</year>) <volume>71</volume>:<fpage>629</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-2488</pub-id><pub-id pub-id-type="pmid">21266353</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alimonti</surname><given-names>A</given-names></name><name><surname>Carracedo</surname><given-names>A</given-names></name><name><surname>Clohessy</surname><given-names>JG</given-names></name><name><surname>Trotman</surname><given-names>LC</given-names></name><name><surname>Nardella</surname><given-names>C</given-names></name><name><surname>Egia</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Subtle variations in Pten dose determine cancer susceptibility</article-title>. <source/>Nat Genet. (<year>2010</year>) <volume>42</volume>:<fpage>454</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ng.556</pub-id><pub-id pub-id-type="pmid">20400965</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naderali</surname><given-names>E</given-names></name><name><surname>Khaki</surname><given-names>AA</given-names></name><name><surname>Rad</surname><given-names>JS</given-names></name><name><surname>Ali-Hemmati</surname><given-names>A</given-names></name><name><surname>Rahmati</surname><given-names>M</given-names></name><name><surname>Charoudeh</surname><given-names>HN</given-names></name></person-group>. <article-title>Regulation and modulation of PTEN activity</article-title>. <source/>Mol Biol Rep. (<year>2018</year>) <volume>45</volume>:<fpage>2869</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-018-4321-6</pub-id><pub-id pub-id-type="pmid">30145641</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geraghty</surname><given-names>AA</given-names></name><name><surname>Lindsay</surname><given-names>KL</given-names></name><name><surname>Alberdi</surname><given-names>G</given-names></name><name><surname>McAuliffe</surname><given-names>FM</given-names></name><name><surname>Gibney</surname><given-names>ER</given-names></name></person-group>. <article-title>Nutrition during pregnancy impacts offspring's epigenetic status—evidence from human and animal studies</article-title>. <source/>Nutr Metab Insights. (<year>2015</year>) <volume>8</volume>(<issue>Suppl. 1</issue>):41–7. <pub-id pub-id-type="doi">10.4137/NMI.S29527</pub-id><pub-id pub-id-type="pmid">26917970</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>CM</given-names></name><name><surname>Morrison</surname><given-names>CD</given-names></name></person-group>. <article-title>The protein leverage hypothesis: a 2019 update for obesity</article-title>. <source/>Obesity. (<year>2019</year>) <volume>27</volume>:<fpage>1221</fpage>. <pub-id pub-id-type="doi">10.1002/oby.22568</pub-id><pub-id pub-id-type="pmid">31339002</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>CM</given-names></name><name><surname>Berthoud</surname><given-names>HR</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name><name><surname>Morrison</surname><given-names>CD</given-names></name></person-group>. <article-title>Homeostatic sensing of dietary protein restriction: A case for FGF21</article-title>. <source/>Front Neuroendocrinol. (<year>2018</year>) <volume>51</volume>:<fpage>125</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2018.06.002</pub-id><pub-id pub-id-type="pmid">29890191</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>FA</given-names></name><name><surname>Holtrop</surname><given-names>G</given-names></name><name><surname>Calder</surname><given-names>AG</given-names></name><name><surname>Anderson</surname><given-names>SE</given-names></name><name><surname>Lobley</surname><given-names>GE</given-names></name><name><surname>Rees</surname><given-names>WD</given-names></name></person-group>. <article-title>Effects of methyl-deficient diets on methionine and homocysteine metabolism in the pregnant rat</article-title>. <source/>Am J Physiol Endocrinol Metab. (<year>2012</year>) <volume>302</volume>:<fpage>E1531</fpage>–<lpage>E40</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00668.2011</pub-id><pub-id pub-id-type="pmid">22454289</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>OS</given-names></name><name><surname>Sant</surname><given-names>KE</given-names></name><name><surname>Dolinoy</surname><given-names>DC</given-names></name></person-group>. <article-title>Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation</article-title>. <source/>J Nutr Biochem. (<year>2012</year>) <volume>23</volume>:<fpage>853</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jnutbio.2012.03.003</pub-id><pub-id pub-id-type="pmid">22749138</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Twinn</surname><given-names>DS</given-names></name><name><surname>Ekizoglou</surname><given-names>S</given-names></name><name><surname>Martin-Gronert</surname><given-names>MS</given-names></name><name><surname>Tarry-Adkins</surname><given-names>J</given-names></name><name><surname>Wayman</surname><given-names>AP</given-names></name><name><surname>Warner</surname><given-names>MJ</given-names></name><etal></etal></person-group>. <article-title>Poor early growth and excessive adult calorie intake independently and additively affect mitogenic signaling and increase mammary tumor susceptibility</article-title>. <source/>Carcinogenesis. (<year>2010</year>) <volume>31</volume>:<fpage>1873</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgq095</pub-id><pub-id pub-id-type="pmid">20460357</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Castorena</surname><given-names>CM</given-names></name><name><surname>Cartee</surname><given-names>GD</given-names></name></person-group>. <article-title>Tissue-specific responses of IGF-1/Insulin and mTOR signaling in calorie restricted rats</article-title>. <source/>PLoS ONE. (<year>2012</year>) <volume>7</volume>:<fpage>e38835</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0038835</pub-id><pub-id pub-id-type="pmid">22701721</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>YX</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name></person-group>. <article-title>Gestational low protein diet in the rat mediatesIgf2gene expression in male offspring via altered hepatic DNA methylation</article-title>. <source/>Epigenetics. (<year>2010</year>) <volume>5</volume>:<fpage>619</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.4161/epi.5.7.12882</pub-id><pub-id pub-id-type="pmid">20671425</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akyol</surname><given-names>A</given-names></name><name><surname>Cetin</surname><given-names>AK</given-names></name><name><surname>Gulec</surname><given-names>A</given-names></name><name><surname>Dasgin</surname><given-names>H</given-names></name><name><surname>Ayaz</surname><given-names>A</given-names></name><name><surname>Onbasilar</surname><given-names>I</given-names></name></person-group>. <article-title>Maternal low-quality protein diet exerts sex-specific effects on plasma amino acid profile and alters hepatic expression of methyltransferases in adult rat offspring</article-title>. <source/>J Dev Orig Health Dis. (<year>2018</year>) <volume>9</volume>:<fpage>409</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1017/S2040174418000132</pub-id><pub-id pub-id-type="pmid">29582727</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altmann</surname><given-names>S</given-names></name><name><surname>Murani</surname><given-names>E</given-names></name><name><surname>Schwerin</surname><given-names>M</given-names></name><name><surname>Metges</surname><given-names>CC</given-names></name><name><surname>Wimmers</surname><given-names>K</given-names></name><name><surname>Ponsuksili</surname><given-names>S</given-names></name></person-group>. <article-title>Maternal dietary protein restriction and excess affects offspring gene expression and methylation of non-SMC subunits of condensin I in liver and skeletal muscle</article-title>. <source/>Epigenetics. (<year>2012</year>) <volume>7</volume>:<fpage>239</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.4161/epi.7.3.19183</pub-id><pub-id pub-id-type="pmid">22430800</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>KP</given-names></name><name><surname>Wanders</surname><given-names>D</given-names></name><name><surname>Orgeron</surname><given-names>M</given-names></name><name><surname>Cortez</surname><given-names>CC</given-names></name><name><surname>Gettys</surname><given-names>TW</given-names></name></person-group>. <article-title>Mechanisms of increased <italic>in vivo</italic> insulin sensitivity by dietary methionine restriction in mice</article-title>. <source/>Diabetes. (<year>2014</year>) <volume>63</volume>:<fpage>3721</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.2337/db14-0464</pub-id><pub-id pub-id-type="pmid">24947368</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacheva</surname><given-names>VP</given-names></name><name><surname>Mellott</surname><given-names>TJ</given-names></name><name><surname>Davison</surname><given-names>JM</given-names></name><name><surname>Wagner</surname><given-names>N</given-names></name><name><surname>Lopez-Coviella</surname><given-names>I</given-names></name><name><surname>Schnitzler</surname><given-names>AC</given-names></name><etal></etal></person-group>. <article-title>Gestational choline deficiency causes global andIgf2Gene DNA hypermethylation by up-regulation ofDnmt1Expression</article-title>. <source/>J Biol Chem. (<year>2007</year>) <volume>282</volume>:<fpage>31777</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M705539200</pub-id><pub-id pub-id-type="pmid">17724018</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Majumder</surname><given-names>S</given-names></name><name><surname>Nuovo</surname><given-names>G</given-names></name><name><surname>Kutay</surname><given-names>H</given-names></name><name><surname>Volinia</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice</article-title>. <source/>Hepatology. (<year>2009</year>) <volume>50</volume>:<fpage>1152</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/hep.23100</pub-id><pub-id pub-id-type="pmid">19711427</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takumi</surname><given-names>S</given-names></name><name><surname>Okamura</surname><given-names>K</given-names></name><name><surname>Yanagisawa</surname><given-names>H</given-names></name><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Nohara</surname><given-names>K</given-names></name></person-group>. <article-title>The effect of a methyl-deficient diet on the global DNA methylation and the DNA methylation regulatory pathways</article-title>. <source/>J Appl Toxicol. (<year>2015</year>) <volume>35</volume>:<fpage>1550</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/jat.3117</pub-id><pub-id pub-id-type="pmid">25690533</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghoshal</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Datta</surname><given-names>J</given-names></name><name><surname>Bai</surname><given-names>S</given-names></name><name><surname>Pogribny</surname><given-names>I</given-names></name><name><surname>Pogribny</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats</article-title>. <source/>J Nutr. (<year>2006</year>) <volume>136</volume>:<fpage>1522</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/jn/136.6.1522</pub-id><pub-id pub-id-type="pmid">16702315</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>T</given-names></name><name><surname>Shibato</surname><given-names>J</given-names></name><name><surname>Rakwal</surname><given-names>R</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Tamura</surname><given-names>G</given-names></name><name><surname>Kuwagata</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Seeking genes responsible for developmental origins of health and disease from the fetal mouse liver following maternal food restriction</article-title>. <source/>Congenit Anom. (<year>2014</year>) <volume>54</volume>:<fpage>195</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1111/cga.12062</pub-id><pub-id pub-id-type="pmid">24754856</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyrou</surname><given-names>M</given-names></name><name><surname>Bourgoin</surname><given-names>L</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name></person-group>. <article-title>PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer</article-title>. <source/>Digest Dis. (<year>2010</year>) <volume>28</volume>:<fpage>236</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1159/000282095</pub-id><pub-id pub-id-type="pmid">20460918</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alchera</surname><given-names>E</given-names></name><name><surname>Rolla</surname><given-names>S</given-names></name><name><surname>Imarisio</surname><given-names>C</given-names></name><name><surname>Bardina</surname><given-names>V</given-names></name><name><surname>Valente</surname><given-names>G</given-names></name><name><surname>Novelli</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity</article-title>. <source/>Transl Res. (<year>2017</year>) <volume>182</volume>:<fpage>75</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2016.11.009</pub-id><pub-id pub-id-type="pmid">28011152</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinciguerra</surname><given-names>M</given-names></name><name><surname>Veyrat–Durebex</surname><given-names>C</given-names></name><name><surname>Moukil</surname><given-names>MA</given-names></name><name><surname>Rubbia–Brandt</surname><given-names>L</given-names></name><name><surname>Rohner–Jeanrenaud</surname><given-names>F</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name></person-group>. <article-title>PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-κBp65/mTOR-dependent mechanism</article-title>. <source/>Gastroenterology. (<year>2008</year>) <volume>134</volume>:<fpage>268</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2007.10.010</pub-id><pub-id pub-id-type="pmid">18166358</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morley</surname><given-names>TS</given-names></name><name><surname>Xia</surname><given-names>JY</given-names></name><name><surname>Scherer</surname><given-names>PE</given-names></name></person-group>. <article-title>Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements</article-title>. <source/>Nat Commun. (<year>2015</year>) <volume>6</volume>:<fpage>7906</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8906</pub-id><pub-id pub-id-type="pmid">26243466</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobi</surname><given-names>EW</given-names></name><name><surname>Lumey</surname><given-names>LH</given-names></name><name><surname>Talens</surname><given-names>RP</given-names></name><name><surname>Kremer</surname><given-names>D</given-names></name><name><surname>Putter</surname><given-names>H</given-names></name><name><surname>Stein</surname><given-names>AD</given-names></name><etal></etal></person-group>. <article-title>DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific</article-title>. <source/>Hum Mol Genet. (<year>2009</year>) <volume>18</volume>:<fpage>4046</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp353</pub-id><pub-id pub-id-type="pmid">19656776</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Miles</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Early-life exposure to severe famine is associated with higher methylation level in the IGF2 gene and higher total cholesterol in late adulthood: the Genomic Research of the Chinese Famine (GRECF) study</article-title>. <source/>Clin Epigenetics. (<year>2019</year>) <volume>11</volume>:<fpage>88</fpage>. <pub-id pub-id-type="doi">10.1186/s13148-019-0676-3</pub-id><pub-id pub-id-type="pmid">31182144</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>de Witte</surname><given-names>LD</given-names></name><name><surname>Houtepen</surname><given-names>LC</given-names></name><name><surname>Nispeling</surname><given-names>DM</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><etal></etal></person-group>. <article-title>DNA methylation changes related to nutritional deprivation: a genome-wide analysis of population and <italic>in vitro</italic> data</article-title>. <source/>Clin Epigenetics. (<year>2019</year>) <volume>11</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/s13148-019-0680-7</pub-id><pub-id pub-id-type="pmid">31097004</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finer</surname><given-names>S</given-names></name><name><surname>Iqbal</surname><given-names>MS</given-names></name><name><surname>Lowe</surname><given-names>R</given-names></name><name><surname>Ogunkolade</surname><given-names>BW</given-names></name><name><surname>Pervin</surname><given-names>S</given-names></name><name><surname>Mathews</surname><given-names>C</given-names></name><etal></etal></person-group>. <article-title>Is famine exposure during developmental life in rural Bangladesh associated with a metabolic and epigenetic signature in young adulthood? a historical cohort study</article-title>. <source/>BMJ Open. (<year>2016</year>) <volume>6</volume>:<fpage>e011768</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2016-011768</pub-id><pub-id pub-id-type="pmid">27881521</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richmond Camilla</surname><given-names>A</given-names></name><name><surname>Shah Manasvi</surname><given-names>S</given-names></name><name><surname>Deary Luke</surname><given-names>T</given-names></name><name><surname>Trotier Danny</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>H</given-names></name><name><surname>Ambruzs Dana</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Dormant intestinal stem cells are regulated by PTEN and nutritional status</article-title>. <source/>Cell Rep. (<year>2015</year>) <volume>13</volume>:<fpage>2403</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.11.035</pub-id><pub-id pub-id-type="pmid">26686631</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sheng</surname><given-names>Z</given-names></name><etal></etal></person-group>. <article-title>Transcriptional regulation of the insulin signaling pathway genes by starvation and 20-hydroxyecdysone in the Bombyx fat body</article-title>. <source/>J Insect Physiol. (<year>2010</year>) <volume>56</volume>:<fpage>1436</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinsphys.2010.02.011</pub-id><pub-id pub-id-type="pmid">20197069</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lie</surname><given-names>S</given-names></name><name><surname>Morrison</surname><given-names>JL</given-names></name><name><surname>Williams-Wyss</surname><given-names>O</given-names></name><name><surname>Suter</surname><given-names>CM</given-names></name><name><surname>Humphreys</surname><given-names>DT</given-names></name><name><surname>Ozanne</surname><given-names>SE</given-names></name><etal></etal></person-group>. <article-title>Impact of embryo number and maternal undernutrition around the time of conception on insulin signaling and gluconeogenic factors and microRNAs in the liver of fetal sheep</article-title>. <source/>Am J Physiol Endocrinol Metab. (<year>2014</year>) <volume>306</volume>:<fpage>E1013</fpage>–<lpage>E24</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00553.2013</pub-id><pub-id pub-id-type="pmid">24496309</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>L-P</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>QW</given-names></name><etal></etal></person-group>. <article-title>Calorie restriction prevents the development of insulin resistance and impaired lipid metabolism in gestational diabetes offspring</article-title>. <source/>Pediatr Res. (<year>2016</year>) <volume>81</volume>:<fpage>663</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/pr.2016.273</pub-id><pub-id pub-id-type="pmid">28024145</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampaio de Freitas</surname><given-names>M</given-names></name><name><surname>Garcia De Souza</surname><given-names>EP</given-names></name><name><surname>Vargas da Silva</surname><given-names>S</given-names></name><name><surname>da Rocha Kaezer</surname><given-names>A</given-names></name><name><surname>da Silva Vieira</surname><given-names>R</given-names></name><name><surname>Sanchez Moura</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Up-regulation of phosphatidylinositol 3-kinase and glucose transporter 4 in muscle of rats subjected to maternal undernutrition</article-title>. <source/>Biochim Biophys Acta. (<year>2003</year>) <volume>1639</volume>:<fpage>8</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/S0925-4439(03)00096-6</pub-id><pub-id pub-id-type="pmid">12943963</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubek</surname><given-names>YA</given-names></name><name><surname>Chang</surname><given-names>K</given-names></name><name><surname>Sivakumar</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Giordano</surname><given-names>MR</given-names></name><name><surname>Fowler</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer</article-title>. <source/>Nat Biotechnol. (<year>2020</year>) <volume>38</volume>:<fpage>90</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0297-6</pub-id><pub-id pub-id-type="pmid">31685958</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sizemore</surname><given-names>GM</given-names></name><name><surname>Balakrishnan</surname><given-names>S</given-names></name><name><surname>Thies</surname><given-names>KA</given-names></name><name><surname>Hammer</surname><given-names>AM</given-names></name><name><surname>Sizemore</surname><given-names>ST</given-names></name><name><surname>Trimboli</surname><given-names>AJ</given-names></name><etal></etal></person-group>. <article-title>Stromal PTEN determines mammary epithelial response to radiotherapy</article-title>. <source/>Nat Commun. (<year>2018</year>) <volume>9</volume>:<fpage>2783</fpage>.<pub-id pub-id-type="pmid">30018330</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raffone</surname><given-names>A</given-names></name><name><surname>Travaglino</surname><given-names>A</given-names></name><name><surname>Saccone</surname><given-names>G</given-names></name><name><surname>Viggiani</surname><given-names>M</given-names></name><name><surname>Giampaolino</surname><given-names>P</given-names></name><name><surname>Insabato</surname><given-names>L</given-names></name><etal></etal></person-group>. <article-title>PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis</article-title>. <source/>Arch Gynecol Obstetr. (<year>2019</year>) <volume>299</volume>:<fpage>1511</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1007/s00404-019-05123-x</pub-id><pub-id pub-id-type="pmid">30915635</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tekcham</surname><given-names>DS</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Shrivastav</surname><given-names>BR</given-names></name><name><surname>Tiwari</surname><given-names>PK</given-names></name></person-group>. <article-title>Epigenetic downregulation of PTEN in gallbladder cancer</article-title>. <source/>J Gastrointest Cancer. (<year>2017</year>) <volume>48</volume>:<fpage>110</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s12029-017-9919-8</pub-id><pub-id pub-id-type="pmid">28124240</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yazdani</surname><given-names>Y</given-names></name><name><surname>Farazmandfar</surname><given-names>T</given-names></name><name><surname>Azadeh</surname><given-names>H</given-names></name><name><surname>Zekavatian</surname><given-names>Z</given-names></name></person-group>. <article-title>The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation</article-title>. <source/>J Biomed Sci. (<year>2016</year>) <volume>23</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.1186/s12929-016-0228-5</pub-id><pub-id pub-id-type="pmid">26787105</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>QF</given-names></name><name><surname>Li</surname><given-names>WT</given-names></name><name><surname>Dong</surname><given-names>HC</given-names></name><name><surname>Chen</surname><given-names>YZ</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>PTENhypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma</article-title>. <source/>Dis Esophagus. (<year>2013</year>) <volume>27</volume>:<fpage>396</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1111/dote.12106</pub-id><pub-id pub-id-type="pmid">23980519</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimm</surname><given-names>O</given-names></name><name><surname>Perren</surname><given-names>A</given-names></name><name><surname>Weng</surname><given-names>L-P</given-names></name><name><surname>Marsh</surname><given-names>DJ</given-names></name><name><surname>Yeh</surname><given-names>JJ</given-names></name><name><surname>Ziebold</surname><given-names>U</given-names></name><etal></etal></person-group>. <article-title>Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors</article-title>. <source/>Am J Pathol. (<year>2000</year>) <volume>156</volume>:<fpage>1693</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)65040-7</pub-id><pub-id pub-id-type="pmid">10793080</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>C</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Prognostic role of PPAR-gamma and PTEN in the renal cell carcinoma</article-title>. <source/>Int J Clin Exp Pathol. (<year>2015</year>) <volume>8</volume>:<fpage>12668</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">26722456</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejeux</surname><given-names>E</given-names></name><name><surname>Rønneberg</surname><given-names>J</given-names></name><name><surname>Solvang</surname><given-names>H</given-names></name><name><surname>Bukholm</surname><given-names>I</given-names></name><name><surname>Geisler</surname><given-names>S</given-names></name><name><surname>Aas</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response</article-title>. <source/>Mol Cancer. (<year>2010</year>) <volume>9</volume>:<fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/1476-4598-9-68</pub-id><pub-id pub-id-type="pmid">20338046</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>W-J</given-names></name><name><surname>Liu</surname><given-names>C-X</given-names></name><name><surname>Chen</surname><given-names>Y-Z</given-names></name><name><surname>Hu</surname><given-names>J-M</given-names></name><name><surname>Jiang</surname><given-names>J-F</given-names></name><etal></etal></person-group>. <article-title>Analysis of PTEN methylation patterns in soft tissue sarcomas by MassARRAY spectrometry</article-title>. <source/>PLoS One. (<year>2013</year>) <volume>8</volume>:<fpage>e62971</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0062971</pub-id><pub-id pub-id-type="pmid">23690972</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yari</surname><given-names>K</given-names></name><name><surname>Payandeh</surname><given-names>M</given-names></name><name><surname>Rahimi</surname><given-names>Z</given-names></name></person-group>. <article-title>Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran</article-title>. <source/>Tumor Biol. (<year>2015</year>) <volume>37</volume>:<fpage>8145</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-015-4731-1</pub-id><pub-id pub-id-type="pmid">26715274</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Kumagai</surname><given-names>T</given-names></name><name><surname>Vora</surname><given-names>J</given-names></name><name><surname>Bose</surname><given-names>N</given-names></name><name><surname>Sehgal</surname><given-names>I</given-names></name><name><surname>Koeffler</surname><given-names>PH</given-names></name><etal></etal></person-group>. <article-title>PTEN promoter is methylated in a proportion of invasive breast cancers</article-title>. <source/>Int J Cancer. (<year>2004</year>) <volume>112</volume>:<fpage>407</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.20447</pub-id><pub-id pub-id-type="pmid">15382065</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>W-J</given-names></name><name><surname>Chang</surname><given-names>X-Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>L-Y</given-names></name><name><surname>Su</surname><given-names>X-H</given-names></name><etal></etal></person-group>. <article-title>Analysis of PTEN expression and promoter methylation in Uyghur patients with mild type 2 diabetes mellitus</article-title>. <source/>Medicine. (<year>2018</year>) <volume>97</volume>:<fpage>e13513</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000013513</pub-id><pub-id pub-id-type="pmid">30544451</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartosch</surname><given-names>C</given-names></name><name><surname>Lopes</surname><given-names>JM</given-names></name><name><surname>Jerónimo</surname><given-names>C</given-names></name></person-group>. <article-title>Epigenetics in endometrial carcinogenesis – part 1: DNA methylation</article-title>. <source/>Epigenomics. (<year>2017</year>) <volume>9</volume>:<fpage>737</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.2217/epi-2016-0166</pub-id><pub-id pub-id-type="pmid">28470096</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dor</surname><given-names>Y</given-names></name><name><surname>Cedar</surname><given-names>H</given-names></name></person-group>. <article-title>Principles of DNA methylation and their implications for biology and medicine</article-title>. <source/>Lancet. (<year>2018</year>) <volume>392</volume>:<fpage>777</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)31268-6</pub-id><pub-id pub-id-type="pmid">30100054</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>JCK</given-names></name></person-group>. <article-title>Thrift: a guide to thrifty genes, thrifty phenotypes and thrifty norms</article-title>. <source/>Int J Obesity. (<year>2009</year>) <volume>33</volume>:<fpage>1331</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2009.175</pub-id><pub-id pub-id-type="pmid">19752875</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobbe</surname><given-names>CB</given-names></name><name><surname>Lapin</surname><given-names>V</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name></person-group>. <article-title>The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey</article-title>. <source/>Oncogene. (<year>2008</year>) <volume>27</volume>:<fpage>5398</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2008.238</pub-id><pub-id pub-id-type="pmid">18794876</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alva</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>GE</given-names></name><name><surname>Escobar</surname><given-names>EE</given-names></name><name><surname>Pyle</surname><given-names>AD</given-names></name></person-group>. <article-title>Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells</article-title>. <source/>Stem Cells. (<year>2011</year>) <volume>29</volume>:<fpage>1952</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/stem.748</pub-id><pub-id pub-id-type="pmid">21948699</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luongo</surname><given-names>F</given-names></name><name><surname>Colonna</surname><given-names>F</given-names></name><name><surname>Calapà</surname><given-names>F</given-names></name><name><surname>Vitale</surname><given-names>S</given-names></name><name><surname>Fiori</surname><given-names>ME</given-names></name><name><surname>De Maria</surname><given-names>R</given-names></name></person-group>. <article-title>PTEN tumor-suppressor: the dam of stemness in cancer</article-title>. <source/>Cancers. (<year>2019</year>) <volume>11</volume>:<fpage>1076</fpage>. <pub-id pub-id-type="doi">10.3390/cancers11081076</pub-id><pub-id pub-id-type="pmid">31366089</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldham</surname><given-names>S</given-names></name><name><surname>Stocker</surname><given-names>H</given-names></name><name><surname>Laffargue</surname><given-names>M</given-names></name><name><surname>Wittwer</surname><given-names>F</given-names></name><name><surname>Wymann</surname><given-names>M</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name></person-group>. <article-title>The Drosophila insulin/IGF receptor controls growth and size by modulating PtdInsP(3) levels</article-title>. <source/>Development. (<year>2002</year>) <volume>129</volume>:<fpage>4103</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">12163412</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowak</surname><given-names>K</given-names></name><name><surname>Seisenbacher</surname><given-names>G</given-names></name><name><surname>Hafen</surname><given-names>E</given-names></name><name><surname>Stocker</surname><given-names>H</given-names></name></person-group>. <article-title>Nutrient restriction enhances the proliferative potential of cells lacking the tumor suppressor PTEN in mitotic tissues</article-title>. <source/>Elife. (<year>2013</year>) <volume>2</volume>:<fpage>e00380</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.00380</pub-id><pub-id pub-id-type="pmid">23853709</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Solomon</surname><given-names>D</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Jin</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Mechanistic analysis of a DNA damage-induced, PTEN-dependent size checkpoint in human cells</article-title>. <source/>Mol Cell Biol. (<year>2011</year>) <volume>31</volume>:<fpage>2756</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.01323-10</pub-id><pub-id pub-id-type="pmid">21536651</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalaany</surname><given-names>NY</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group>. <article-title>Tumours with PI3K activation are resistant to dietary restriction</article-title>. <source/>Nature. (<year>2009</year>) <volume>458</volume>:<fpage>725</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1038/nature07782</pub-id><pub-id pub-id-type="pmid">19279572</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calastretti</surname><given-names>A</given-names></name><name><surname>Gatti</surname><given-names>G</given-names></name><name><surname>Quaresmini</surname><given-names>C</given-names></name><name><surname>Bevilacqua</surname><given-names>A</given-names></name></person-group>. <article-title>Down-modulation of Bcl-2 sensitizes PTEN-mutated prostate cancer cells to starvation and taxanes</article-title>. <source/>Prostate. (<year>2014</year>) <volume>74</volume>:<fpage>1411</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/pros.22857</pub-id><pub-id pub-id-type="pmid">25111376</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Cao</surname><given-names>I</given-names></name><name><surname>Song Min</surname><given-names>S</given-names></name><name><surname>Hobbs Robin</surname><given-names>M</given-names></name><name><surname>Laurent</surname><given-names>G</given-names></name><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>de Boer Vincent</surname><given-names>CJ</given-names></name><etal></etal></person-group>. <article-title>Systemic elevation of PTEN induces a tumor-suppressive metabolic state</article-title>. <source/>Cell. (<year>2012</year>) <volume>149</volume>:<fpage>49</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.030</pub-id><pub-id pub-id-type="pmid">22401813</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortega-Molina</surname><given-names>A</given-names></name><name><surname>Efeyan</surname><given-names>A</given-names></name><name><surname>Lopez-Guadamillas</surname><given-names>E</given-names></name><name><surname>Muñoz-Martin</surname><given-names>M</given-names></name><name><surname>Gómez-López</surname><given-names>G</given-names></name><name><surname>Cañamero</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Pten positively regulates brown adipose function, energy expenditure, and longevity</article-title>. <source/>Cell Metab. (<year>2012</year>) <volume>15</volume>:<fpage>382</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.02.001</pub-id><pub-id pub-id-type="pmid">22405073</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goo</surname><given-names>CK</given-names></name><name><surname>Lim</surname><given-names>HY</given-names></name><name><surname>Ho</surname><given-names>QS</given-names></name><name><surname>Too</surname><given-names>H-P</given-names></name><name><surname>Clement</surname><given-names>M-V</given-names></name><name><surname>Wong</surname><given-names>KP</given-names></name></person-group>. <article-title>PTEN/Akt signaling controls mitochondrial respiratory capacity through 4E-BP1</article-title>. <source/>PLoS One. (<year>2012</year>) <volume>7</volume>:<fpage>e45806</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0045806</pub-id><pub-id pub-id-type="pmid">23049865</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name><etal></etal></person-group>. <article-title>Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN</article-title>. <source/>Sci Rep. (<year>2015</year>) <volume>5</volume>:<fpage>16262</fpage>. <pub-id pub-id-type="doi">10.1038/srep16262</pub-id><pub-id pub-id-type="pmid">26548909</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberti</surname><given-names>MV</given-names></name><name><surname>Locasale</surname><given-names>JW</given-names></name></person-group>
<article-title>The warburg effect: how does it benefit cancer cells?</article-title>
<source/>Trends Biochem Sci. (<year>2016</year>) <volume>41</volume>:<fpage>211</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibs.2015.12.001</pub-id><pub-id pub-id-type="pmid">26778478</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>A</given-names></name><name><surname>Barber</surname><given-names>TM</given-names></name><name><surname>Van de Bunt</surname><given-names>M</given-names></name><name><surname>Rudge</surname><given-names>SA</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Lachlan</surname><given-names>KL</given-names></name><etal></etal></person-group>. <article-title>PTEN mutations as a cause of constitutive insulin sensitivity and obesity</article-title>. <source/>N Engl J Med. (<year>2012</year>) <volume>367</volume>:<fpage>1002</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1113966</pub-id><pub-id pub-id-type="pmid">22970944</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>F</given-names></name></person-group>. <article-title>PTEN mutations increase insulin sensitivity and obesity</article-title>. <source/>Nat Rev Endocrinol. (<year>2012</year>) <volume>8</volume>:<fpage>698</fpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2012.186</pub-id><pub-id pub-id-type="pmid">23032179</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samaan</surname><given-names>MC</given-names></name><name><surname>Anand</surname><given-names>SS</given-names></name><name><surname>Sharma</surname><given-names>AM</given-names></name><name><surname>Samjoo</surname><given-names>IA</given-names></name><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name></person-group>. <article-title>Sex differences in skeletal muscle Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) levels: A cross-sectional study</article-title>. <source/>Sci Rep. (<year>2015</year>) <volume>5</volume>:<fpage>9154</fpage>. <pub-id pub-id-type="doi">10.1038/srep09154</pub-id><pub-id pub-id-type="pmid">25777795</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirstein</surname><given-names>A</given-names></name><name><surname>Penke</surname><given-names>M</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><name><surname>Garten</surname><given-names>A</given-names></name></person-group>
<article-title>Reduced PTEN levels enhance the proliferation as well as differentiation of preadipocytes</article-title>. <source/>Endocr Abstracts. (<year>2018</year>) <volume>59</volume>:<fpage>172</fpage>
<pub-id pub-id-type="doi">10.1530/endoabs.59.P172</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirstein</surname><given-names>AS</given-names></name><name><surname>Augustin</surname><given-names>A</given-names></name><name><surname>Penke</surname><given-names>M</given-names></name><name><surname>Cea</surname><given-names>M</given-names></name><name><surname>Korner</surname><given-names>A</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><etal></etal></person-group>. <article-title>The novel Phosphatidylinositol-3-Kinase (PI3K) inhibitor alpelisib effectively inhibits growth of PTEN-haploinsufficient lipoma cells</article-title>. <source/>Cancers (Basel). (<year>2019</year>) <volume>11</volume>:<fpage>E1586</fpage>. <pub-id pub-id-type="doi">10.3390/cancers11101586</pub-id><pub-id pub-id-type="pmid">31627436</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ramakrishnan</surname><given-names>SK</given-names></name><name><surname>Khuder</surname><given-names>SS</given-names></name><name><surname>Kaw</surname><given-names>MK</given-names></name><name><surname>Muturi</surname><given-names>HT</given-names></name><name><surname>Lester</surname><given-names>SG</given-names></name><etal></etal></person-group>. <article-title>High-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor gene</article-title>. <source/>Mol Metab. (<year>2015</year>) <volume>4</volume>:<fpage>186</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2014.12.011</pub-id><pub-id pub-id-type="pmid">25737954</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>KTT</given-names></name><name><surname>Tajmir</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>CH</given-names></name><name><surname>Liadis</surname><given-names>N</given-names></name><name><surname>Zhu</surname><given-names>XD</given-names></name><name><surname>Eweida</surname><given-names>M</given-names></name><etal></etal></person-group>. <article-title>Essential role of Pten in body size determination and pancreatic -cell homeostasis <italic>in vivo</italic></article-title>. <source/>Mol Cell Biol. (<year>2006</year>) <volume>26</volume>:<fpage>4511</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.00238-06</pub-id><pub-id pub-id-type="pmid">16738317</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>D</given-names></name><name><surname>Nguyen</surname><given-names>K-TT</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Schroer</surname><given-names>SA</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name><etal></etal></person-group>. <article-title>Partial deletion of Ptenin the hypothalamus leads to growth defects that cannot be rescued by exogenous growth hormone</article-title>. <source/>Endocrinology. (<year>2008</year>) <volume>149</volume>:<fpage>4382</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1210/en.2007-1761</pub-id><pub-id pub-id-type="pmid">18499759</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cristofano</surname><given-names>AD</given-names></name><name><surname>Pesce</surname><given-names>B</given-names></name><name><surname>Cordon-Cardo</surname><given-names>C</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>Pten is essential for embryonic development and tumour suppression</article-title>. <source/>Nat Genet. (<year>1998</year>) <volume>19</volume>:<fpage>348</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/1235</pub-id><pub-id pub-id-type="pmid">9697695</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plum</surname><given-names>L</given-names></name></person-group>. <article-title>Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity</article-title>. <source/>J Clin Invest. (<year>2006</year>) <volume>116</volume>:<fpage>1886</fpage>–<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1172/JCI27123</pub-id><pub-id pub-id-type="pmid">16794735</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Lee</surname><given-names>IH</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sheng</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>PTEN expression contributes to the regulation of muscle protein degradation in diabetes</article-title>. <source/>Diabetes. (<year>2007</year>) <volume>56</volume>:<fpage>2449</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.2337/db06-1731</pub-id><pub-id pub-id-type="pmid">17623817</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaghoob Nezhad</surname><given-names>F</given-names></name><name><surname>Verbrugge</surname><given-names>SAJ</given-names></name><name><surname>Schönfelder</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>L</given-names></name><name><surname>Hrabě de Angelis</surname><given-names>M</given-names></name><name><surname>Wackerhage</surname><given-names>H</given-names></name></person-group>. <article-title>Genes whose gain or loss-of-function increases endurance performance in mice: a systematic literature review</article-title>. <source/>Front Physiol. (<year>2019</year>) <volume>10</volume>:<fpage>262</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2019.00262</pub-id><pub-id pub-id-type="pmid">30967789</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rademacher</surname><given-names>S</given-names></name><name><surname>Eickholt</surname><given-names>BJ</given-names></name></person-group>. <article-title>PTEN in autism and neurodevelopmental disorders</article-title>. <source/>Cold Spring Harb Perspect Med. (<year>2019</year>) <volume>9</volume>:<fpage>a036780</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a036780</pub-id><pub-id pub-id-type="pmid">31427284</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Adhikari</surname><given-names>D</given-names></name><name><surname>Jagarlamudi</surname><given-names>K</given-names></name><name><surname>Rajareddy</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Oocyte-specific deletion of pten causes premature activation of the primordial follicle pool</article-title>. <source/>Science. (<year>2008</year>) <volume>319</volume>:<fpage>611</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1126/science.1152257</pub-id><pub-id pub-id-type="pmid">18239123</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuo</surname><given-names>Y</given-names></name><name><surname>Hua</surname><given-names>L</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Fibroblast growth factor 21 coordinates adiponectin to mediate the beneficial effects of low-protein diet on primordial follicle reserve</article-title>. <source/>EBioMed. (<year>2019</year>) <volume>41</volume>:<fpage>623</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.ebiom.2019.02.020</pub-id><pub-id pub-id-type="pmid">30772303</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen-Li</surname><given-names>H</given-names></name><name><surname>Koujak</surname><given-names>S</given-names></name><name><surname>Szablocs</surname><given-names>M</given-names></name><name><surname>Parsons</surname><given-names>R</given-names></name></person-group>. <article-title>Reduction ofPtendose leads to neoplastic development in multiple organs ofPtenshRNAmice</article-title>. <source/>Cancer Biol Ther. (<year>2010</year>) <volume>10</volume>:<fpage>1194</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.4161/cbt.10.11.13814</pub-id><pub-id pub-id-type="pmid">20980828</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolb</surname><given-names>H</given-names></name><name><surname>Stumvoll</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>W</given-names></name><name><surname>Kempf</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name></person-group>. <article-title>Insulin translates unfavourable lifestyle into obesity</article-title>. <source/>BMC Med. (<year>2018</year>) <volume>16</volume>:<fpage>232</fpage>. <pub-id pub-id-type="doi">10.1186/s12916-018-1225-1</pub-id><pub-id pub-id-type="pmid">30541568</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanik</surname><given-names>MH</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Skrha</surname><given-names>J</given-names></name><name><surname>Dankner</surname><given-names>R</given-names></name><name><surname>Zick</surname><given-names>Y</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name></person-group>
<article-title>Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?</article-title>
<source/>Diabetes Care. (<year>2008</year>) <volume>31</volume>(<issue>Suppl. 2</issue>):S262–8. <pub-id pub-id-type="doi">10.2337/dc08-s264</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulman</surname><given-names>GI</given-names></name></person-group>
<article-title>Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease</article-title>. <source/>N Engl J Med. (<year>2014</year>) <volume>371</volume>:<fpage>1131</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1011035</pub-id><pub-id pub-id-type="pmid">25229917</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stiles</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Stahl</surname><given-names>A</given-names></name><name><surname>Bassilian</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Kim</surname><given-names>Y-J</given-names></name><etal></etal></person-group>. <article-title>Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2004</year>) <volume>101</volume>:<fpage>2082</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0308617100</pub-id><pub-id pub-id-type="pmid">14769918</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurlawalla-Martinez</surname><given-names>C</given-names></name><name><surname>Stiles</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Devaskar</surname><given-names>SU</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name></person-group>. <article-title>Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue</article-title>. <source/>Mol Cell Biol. (<year>2005</year>) <volume>25</volume>:<fpage>2498</fpage>–<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.25.6.2498-2510.2005</pub-id><pub-id pub-id-type="pmid">15743841</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijesekara</surname><given-names>N</given-names></name><name><surname>Konrad</surname><given-names>D</given-names></name><name><surname>Eweida</surname><given-names>M</given-names></name><name><surname>Jefferies</surname><given-names>C</given-names></name><name><surname>Liadis</surname><given-names>N</given-names></name><name><surname>Giacca</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Muscle-specific Pten deletion protects against insulin resistance and diabetes</article-title>. <source/>Mol Cell Biol. (<year>2005</year>) <volume>25</volume>:<fpage>1135</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.25.3.1135-1145.2005</pub-id><pub-id pub-id-type="pmid">15657439</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stiles</surname><given-names>BL</given-names></name><name><surname>Kuralwalla-Martinez</surname><given-names>C</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Gregorian</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Selective deletion of Pten in pancreatic cells leads to increased islet mass and resistance to STZ-induced diabetes</article-title>. <source/>Mol Cell Biol. (<year>2006</year>) <volume>26</volume>:<fpage>2772</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.26.7.2772-2781.2006</pub-id><pub-id pub-id-type="pmid">16537919</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Opland</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Luk</surname><given-names>CT</given-names></name><name><surname>Schroer</surname><given-names>SA</given-names></name><name><surname>Allison</surname><given-names>MB</given-names></name><etal></etal></person-group>. <article-title>Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex</article-title>. <source/>Nat Med. (<year>2014</year>) <volume>20</volume>:<fpage>484</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/nm.3527</pub-id><pub-id pub-id-type="pmid">24747746</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>M</given-names></name><name><surname>McKay</surname><given-names>RA</given-names></name><name><surname>Popoff</surname><given-names>IJ</given-names></name><name><surname>Gaarde</surname><given-names>WA</given-names></name><name><surname>Witchell</surname><given-names>D</given-names></name><name><surname>Murray</surname><given-names>SF</given-names></name><etal></etal></person-group>. <article-title>Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice</article-title>. <source/>Diabetes. (<year>2002</year>) <volume>51</volume>:<fpage>1028</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.51.4.1028</pub-id><pub-id pub-id-type="pmid">11916922</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Gurmaches</surname><given-names>J</given-names></name><name><surname>Hung</surname><given-names>CM</given-names></name><name><surname>Sparks</surname><given-names>CA</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Guertin</surname><given-names>DA</given-names></name></person-group>. <article-title>PTEN loss in the Myf5 lineage redistributes body fat and reveals subsets of white adipocytes that arise from Myf5 precursors</article-title>. <source/>Cell Metab. (<year>2012</year>) <volume>16</volume>:<fpage>348</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2012.08.003</pub-id><pub-id pub-id-type="pmid">22940198</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Queen</surname><given-names>NJ</given-names></name><name><surname>McMurphy</surname><given-names>TB</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name></person-group>
<article-title>Adipose PTEN regulates adult adipose tissue homeostasis and redistribution via a PTEN-leptin-sympathetic loop</article-title>. <source/>Mol Metab. (<year>2019</year>) <volume>30</volume>:<fpage>48</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2019.09.008</pub-id><pub-id pub-id-type="pmid">31767180</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>JC</given-names></name><name><surname>Sawaya</surname><given-names>AL</given-names></name><name><surname>Wibaek</surname><given-names>R</given-names></name><name><surname>Mwangome</surname><given-names>M</given-names></name><name><surname>Poullas</surname><given-names>MS</given-names></name><name><surname>Yajnik</surname><given-names>CS</given-names></name><etal></etal></person-group>. <article-title>The double burden of malnutrition: aetiological pathways and consequences for health</article-title>. <source/>Lancet. (<year>2020</year>) <volume>395</volume>:<fpage>75</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(19)32472-9</pub-id><pub-id pub-id-type="pmid">31852605</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yajnik</surname><given-names>CS</given-names></name><name><surname>Lubree</surname><given-names>HG</given-names></name><name><surname>Rege</surname><given-names>SS</given-names></name><name><surname>Naik</surname><given-names>SS</given-names></name><name><surname>Deshpande</surname><given-names>JA</given-names></name><name><surname>Deshpande</surname><given-names>SS</given-names></name><etal></etal></person-group>. <article-title>Adiposity and hyperinsulinemia in Indians are present at birth</article-title>. <source/>J Clin Endocrinol Metab. (<year>2002</year>) <volume>87</volume>:<fpage>5575</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2002-020434</pub-id><pub-id pub-id-type="pmid">12466355</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finer</surname><given-names>S</given-names></name><name><surname>Saravanan</surname><given-names>P</given-names></name><name><surname>Hitman</surname><given-names>G</given-names></name><name><surname>Yajnik</surname><given-names>C</given-names></name></person-group>. <article-title>The role of the one-carbon cycle in the developmental origins of Type 2 diabetes and obesity</article-title>. <source/>Diabetic Med. (<year>2014</year>) <volume>31</volume>:<fpage>263</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1111/dme.12390</pub-id><pub-id pub-id-type="pmid">24344881</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lubecka-Pietruszewska</surname><given-names>K</given-names></name><name><surname>Kaufman-Szymczyk</surname><given-names>A</given-names></name><name><surname>Stefanska</surname><given-names>B</given-names></name><name><surname>Fabianowska-Majewska</surname><given-names>K</given-names></name></person-group>. <article-title>Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer</article-title>. <source/>Biochem Biophys Res Commun. (<year>2013</year>) <volume>430</volume>:<fpage>623</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.11.103</pub-id><pub-id pub-id-type="pmid">23219837</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yajnik</surname><given-names>CS</given-names></name><name><surname>Deshpande</surname><given-names>SS</given-names></name><name><surname>Jackson</surname><given-names>AA</given-names></name><name><surname>Refsum</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Fisher</surname><given-names>DJ</given-names></name><etal></etal></person-group>. <article-title>Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune maternal nutrition study</article-title>. <source/>Diabetologia. (<year>2008</year>) <volume>51</volume>:<fpage>29</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-007-0793-y</pub-id><pub-id pub-id-type="pmid">17851649</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>J</given-names></name></person-group>. <article-title>The double puzzle of diabetes</article-title>. <source/>Nature. (<year>2003</year>) <volume>423</volume>:<fpage>599</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1038/423599a</pub-id><pub-id pub-id-type="pmid">12789325</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midgley</surname><given-names>R</given-names></name><name><surname>Kerr</surname><given-names>DJ</given-names></name></person-group>. <article-title>Capecitabine: have we got the dose right?</article-title>
<source/>Nat Clin Pract Oncol. (<year>2009</year>) <volume>6</volume>:<fpage>17</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/ncponc1240</pub-id><pub-id pub-id-type="pmid">18936793</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Lee</surname><given-names>JO</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>You</surname><given-names>GY</given-names></name><name><surname>Moon</surname><given-names>JW</given-names></name><etal></etal></person-group>. <article-title>Metformin sensitizes insulin signaling through AMPK-mediated pten down-regulation in preadipocyte 3T3-L1 cells</article-title>. <source/>J Cell Biochem. (<year>2011</year>) <volume>112</volume>:<fpage>1259</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.23000</pub-id><pub-id pub-id-type="pmid">21465524</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinciguerra</surname><given-names>M</given-names></name><name><surname>Sgroi</surname><given-names>A</given-names></name><name><surname>Veyrat-Durebex</surname><given-names>C</given-names></name><name><surname>Rubbia-Brandt</surname><given-names>L</given-names></name><name><surname>Buhler</surname><given-names>LH</given-names></name><name><surname>Foti</surname><given-names>M</given-names></name></person-group>. <article-title>Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes</article-title>. <source/>Hepatology. (<year>2008</year>) <volume>49</volume>:<fpage>1176</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1002/hep.22737</pub-id><pub-id pub-id-type="pmid">19072831</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>YT</given-names></name><name><surname>Tsao</surname><given-names>CJ</given-names></name><name><surname>Liu</surname><given-names>IM</given-names></name><name><surname>Liou</surname><given-names>SS</given-names></name><name><surname>Cheng</surname><given-names>JT</given-names></name></person-group>. <article-title>Increase of PTEN gene expression in insulin resistance</article-title>. <source/>Horm Metab Res. (<year>2004</year>) <volume>36</volume>:<fpage>662</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1055/s-2004-826016</pub-id><pub-id pub-id-type="pmid">15523589</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodakoski</surname><given-names>C</given-names></name><name><surname>Hopkins</surname><given-names>BD</given-names></name><name><surname>Barrows</surname><given-names>D</given-names></name><name><surname>Mense</surname><given-names>SM</given-names></name><name><surname>Keniry</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>KE</given-names></name><etal></etal></person-group>. <article-title>Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2014</year>) <volume>111</volume>:<fpage>155</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1213773111</pub-id><pub-id pub-id-type="pmid">24367090</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campión</surname><given-names>J</given-names></name><name><surname>Milagro</surname><given-names>FI</given-names></name><name><surname>Martínez</surname><given-names>JA</given-names></name></person-group>. <article-title>Individuality and epigenetics in obesity</article-title>. <source/>Obesity Rev. (<year>2009</year>) <volume>10</volume>:<fpage>383</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/j.1467-789X.2009.00595.x</pub-id><pub-id pub-id-type="pmid">19413700</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashemi</surname><given-names>M</given-names></name><name><surname>Rezaei</surname><given-names>H</given-names></name><name><surname>Eskandari-Nasab</surname><given-names>E</given-names></name><name><surname>Kaykhaei</surname><given-names>M-A</given-names></name><name><surname>Taheri</surname><given-names>M</given-names></name></person-group>. <article-title>Association of promoter methylation and 32-bp deletion of the PTEN gene with susceptibility to metabolic syndrome</article-title>. <source/>Mol Med Rep. (<year>2012</year>) <volume>7</volume>:<fpage>342</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2012.1174</pub-id><pub-id pub-id-type="pmid">23138198</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berstein</surname><given-names>LM</given-names></name><name><surname>Iyevleva</surname><given-names>AG</given-names></name><name><surname>Mukhina</surname><given-names>MS</given-names></name><name><surname>Vasilyev</surname><given-names>DA</given-names></name><name><surname>Poroshina</surname><given-names>TE</given-names></name></person-group>
<article-title>Features of omental adipose tissue in endometrial cancer patients with ‘standard' or ‘metabolically healthy' obesity: associations with tumor process characteristics</article-title>. <source/>SpringerPlus. (<year>2016</year>) <volume>5</volume>:<fpage>1900</fpage>
<pub-id pub-id-type="doi">10.1186/s40064-016-3582-6</pub-id><pub-id pub-id-type="pmid">27853670</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>H</given-names></name><name><surname>Sasaoka</surname><given-names>T</given-names></name><name><surname>Kagawa</surname><given-names>S</given-names></name><name><surname>Murakami</surname><given-names>S</given-names></name><name><surname>Fukui</surname><given-names>K</given-names></name><name><surname>Kawagishi</surname><given-names>Y</given-names></name><etal></etal></person-group>. <article-title>Association of the polymorphisms in the 5′-untranslated region of PTEN gene with type 2 diabetes in a Japanese population</article-title>. <source/>FEBS Lett. (<year>2003</year>) <volume>554</volume>:<fpage>450</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(03)01225-0</pub-id><pub-id pub-id-type="pmid">14623110</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>S</given-names></name><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><etal></etal></person-group>. <article-title>Associations of the PTEN −9C&gt;G polymorphism with insulin sensitivity and central obesity in Chinese</article-title>. <source/>Gene. (<year>2013</year>) <volume>527</volume>:<fpage>545</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2013.06.026</pub-id><pub-id pub-id-type="pmid">23796801</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>L</given-names></name><name><surname>Jensen</surname><given-names>JN</given-names></name><name><surname>Ekstrøm</surname><given-names>CT</given-names></name><name><surname>Vestergaard</surname><given-names>H</given-names></name><name><surname>Hansen</surname><given-names>T</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name></person-group>. <article-title>Studies of variability in the PTEN gene among Danish caucasian patients with type II diabetes mellitus</article-title>. <source/>Diabetologia. (<year>2001</year>) <volume>44</volume>:<fpage>237</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1007/s001250051605</pub-id><pub-id pub-id-type="pmid">11270682</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blouin</surname><given-names>M-J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zakikhani</surname><given-names>M</given-names></name><name><surname>Algire</surname><given-names>C</given-names></name><name><surname>Piura</surname><given-names>E</given-names></name><name><surname>Pollak</surname><given-names>M</given-names></name></person-group>. <article-title>Loss of function of PTEN alters the relationship between glucose concentration and cell proliferation, increases glycolysis, and sensitizes cells to 2-deoxyglucose</article-title>. <source/>Cancer Lett. (<year>2010</year>) <volume>289</volume>:<fpage>246</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2009.08.021</pub-id><pub-id pub-id-type="pmid">19744772</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>CJ</given-names></name><name><surname>Ruderman</surname><given-names>NB</given-names></name><name><surname>Kahn</surname><given-names>SE</given-names></name><name><surname>Pedersen</surname><given-names>O</given-names></name><name><surname>Prentki</surname><given-names>M</given-names></name></person-group>
<article-title>Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes</article-title>. <source/>Diabetes. (<year>2015</year>) <volume>64</volume>:<fpage>673</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.2337/db14-0694</pub-id><pub-id pub-id-type="pmid">25713189</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Bandyopadhyay</surname><given-names>G</given-names></name><name><surname>Oh</surname><given-names>D</given-names></name><name><surname>Imamura</surname><given-names>T</given-names></name><etal></etal></person-group>. <article-title>Hematopoietic-derived galectin-3 causes cellular and systemic insulin resistance</article-title>. <source/>Cell. (<year>2016</year>) <volume>167</volume>:<fpage>973</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.10.025</pub-id><pub-id pub-id-type="pmid">27814523</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trepanowski</surname><given-names>JF</given-names></name><name><surname>Mey</surname><given-names>J</given-names></name><name><surname>Varady</surname><given-names>KA</given-names></name></person-group>. <article-title>Fetuin-A: a novel link between obesity and related complications</article-title>. <source/>Int J Obes (Lond). (<year>2015</year>) <volume>39</volume>:<fpage>734</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/ijo.2014.203</pub-id><pub-id pub-id-type="pmid">25468829</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XL</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Youker</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>MX</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>LeMaire</surname><given-names>SA</given-names></name><etal></etal></person-group>
<article-title>Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase</article-title>. <source/>Diabetes. (<year>2006</year>) <volume>55</volume>:<fpage>2301</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.2337/db05-1574</pub-id><pub-id pub-id-type="pmid">16873694</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulger</surname><given-names>DA</given-names></name><name><surname>Conley</surname><given-names>J</given-names></name><name><surname>Conner</surname><given-names>SH</given-names></name><name><surname>Majumdar</surname><given-names>G</given-names></name><name><surname>Solomon</surname><given-names>SS</given-names></name></person-group>. <article-title>Role of PTEN in TNFα induced insulin resistance</article-title>. <source/>Biochem Biophys Res Commun. (<year>2015</year>) <volume>461</volume>:<fpage>533</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2015.04.063</pub-id><pub-id pub-id-type="pmid">25918024</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>YH</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Gan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>LeMaire</surname><given-names>SA</given-names></name><etal></etal></person-group>. <article-title>Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling</article-title>. <source/>J Biol Chem. (<year>2006</year>) <volume>281</volume>:<fpage>7727</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M511105200</pub-id><pub-id pub-id-type="pmid">16418168</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>K</given-names></name><name><surname>Miner</surname><given-names>J</given-names></name></person-group>. <article-title>Role of resistin in insulin sensitivity in rodents and humans</article-title>. <source/>Curr Protein Pept Sci. (<year>2009</year>) <volume>10</volume>:<fpage>96</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.2174/138920309787315239</pub-id><pub-id pub-id-type="pmid">19275676</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papa</surname><given-names>A</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>The PTEN-PI3K axis in cancer</article-title>. <source/>Biomolecular. (<year>2019</year>) <volume>9</volume>:<fpage>153</fpage>. <pub-id pub-id-type="doi">10.3390/biom9040153</pub-id><pub-id pub-id-type="pmid">30999672</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Álvarez-Garcia</surname><given-names>V</given-names></name><name><surname>Tawil</surname><given-names>Y</given-names></name><name><surname>Wise</surname><given-names>HM</given-names></name><name><surname>Leslie</surname><given-names>NR</given-names></name></person-group>. <article-title>Mechanisms of PTEN loss in cancer: it's all about diversity</article-title>. <source/>Sem Cancer Biol. (<year>2019</year>) <volume>59</volume>:<fpage>66</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2019.02.001</pub-id><pub-id pub-id-type="pmid">30738865</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nardella</surname><given-names>C</given-names></name><name><surname>Carracedo</surname><given-names>A</given-names></name><name><surname>Salmena</surname><given-names>L</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group>. <article-title>Faithfull modeling of PTEN loss driven diseases in the mouse</article-title>. <source/>Curr Topics Microbiol Immunol. (<year>2010</year>) <volume>347</volume>:<fpage>135</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1007/82_2010_62</pub-id><pub-id pub-id-type="pmid">20549475</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>CW</given-names></name><name><surname>Maxwell</surname><given-names>P</given-names></name><name><surname>Alvi</surname><given-names>MA</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Waugh</surname><given-names>D</given-names></name><name><surname>Mills</surname><given-names>I</given-names></name><etal></etal></person-group>. <article-title>A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases</article-title>. <source/>J Pathol Clin Res. (<year>2018</year>) <volume>4</volume>:<fpage>103</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/cjp2.94</pub-id><pub-id pub-id-type="pmid">29665325</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siddiqui</surname><given-names>S</given-names></name><name><surname>Akhter</surname><given-names>N</given-names></name><name><surname>Deo</surname><given-names>SVS</given-names></name><name><surname>Shukla</surname><given-names>NK</given-names></name><name><surname>Husain</surname><given-names>SA</given-names></name></person-group>. <article-title>A study on promoter methylation of PTEN in sporadic breast cancer patients from North India</article-title>. <source/>Breast Cancer. (<year>2016</year>) <volume>23</volume>:<fpage>922</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s12282-015-0665-0</pub-id><pub-id pub-id-type="pmid">26754093</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Uemura</surname><given-names>M</given-names></name><name><surname>Nonomura</surname><given-names>N</given-names></name></person-group>. <article-title>Metformin inhibits prostate cancer growth induced by a high-fat diet in Pten -deficient model mice</article-title>. <source/>Int J Urol. (<year>2018</year>) <volume>26</volume>:<fpage>307</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/iju.13847</pub-id><pub-id pub-id-type="pmid">30458584</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Cline</surname><given-names>M</given-names></name><name><surname>Maxwell</surname><given-names>LG</given-names></name><name><surname>Berrigan</surname><given-names>D</given-names></name><name><surname>Rodriguez</surname><given-names>G</given-names></name><name><surname>Warri</surname><given-names>A</given-names></name><etal></etal></person-group>. <article-title>Dietary Vitamin D exposure prevents obesity-induced increase in endometrial cancer in Pten+/− Mice</article-title>. <source/>Cancer Prev Res. (<year>2010</year>) <volume>3</volume>:<fpage>1246</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-10-0088</pub-id><pub-id pub-id-type="pmid">20858763</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauby-Secretan</surname><given-names>B</given-names></name><name><surname>Scoccianti</surname><given-names>C</given-names></name><name><surname>Loomis</surname><given-names>D</given-names></name><name><surname>Grosse</surname><given-names>Y</given-names></name><name><surname>Bianchini</surname><given-names>F</given-names></name><name><surname>Straif</surname><given-names>K</given-names></name></person-group>. <article-title>Body fatness and cancer — viewpoint of the IARC working group</article-title>. <source/>N Engl J Med. (<year>2016</year>) <volume>375</volume>:<fpage>794</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMsr1606602</pub-id><pub-id pub-id-type="pmid">27557308</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westin</surname><given-names>SN</given-names></name><name><surname>Ju</surname><given-names>Z</given-names></name><name><surname>Broaddus</surname><given-names>RR</given-names></name><name><surname>Krakstad</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Pal</surname><given-names>N</given-names></name><etal></etal></person-group>. <article-title>PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients</article-title>. <source/>Mol Oncol. (<year>2015</year>) <volume>9</volume>:<fpage>1694</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1016/j.molonc.2015.04.014</pub-id><pub-id pub-id-type="pmid">26045339</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>GK</given-names></name><name><surname>Mutton</surname><given-names>LN</given-names></name><name><surname>Khalili</surname><given-names>M</given-names></name><name><surname>McMullin</surname><given-names>RP</given-names></name><name><surname>Hicks</surname><given-names>JL</given-names></name><name><surname>Bianchi-Frias</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Combined MYC activation and pten loss are sufficient to create genomic instability and lethal metastatic prostate cancer</article-title>. <source/>Cancer Res. (<year>2015</year>) <volume>76</volume>:<fpage>283</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-3280</pub-id><pub-id pub-id-type="pmid">26554830</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>D</given-names></name><name><surname>Benham</surname><given-names>V</given-names></name><name><surname>Bullard</surname><given-names>B</given-names></name><name><surname>Kearney</surname><given-names>T</given-names></name><name><surname>Hsia</surname><given-names>HC</given-names></name><name><surname>Gibbon</surname><given-names>D</given-names></name><etal></etal></person-group>. <article-title>Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer</article-title>. <source/>Oncogene. (<year>2017</year>) <volume>36</volume>:<fpage>6668</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2017.278</pub-id><pub-id pub-id-type="pmid">28783178</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benham</surname><given-names>V</given-names></name><name><surname>Chakraborty</surname><given-names>D</given-names></name><name><surname>Bullard</surname><given-names>B</given-names></name><name><surname>Bernard</surname><given-names>JJ</given-names></name></person-group>
<article-title>A role for FGF2 in visceral adiposity-associated mammary epithelial transformation</article-title>. <source/>Adioicyte. (<year>2018</year>) <volume>7</volume>:<fpage>113</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1158/1538-7445.AM2018-1275</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byron</surname><given-names>SA</given-names></name><name><surname>Gartside</surname><given-names>MG</given-names></name><name><surname>Wellens</surname><given-names>CL</given-names></name><name><surname>Mallon</surname><given-names>MA</given-names></name><name><surname>Keenan</surname><given-names>JB</given-names></name><name><surname>Powell</surname><given-names>MA</given-names></name><etal></etal></person-group>. <article-title>Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation</article-title>. <source/>Cancer Res. (<year>2008</year>) <volume>68</volume>:<fpage>6902</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-0770</pub-id><pub-id pub-id-type="pmid">18757403</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Karatas</surname><given-names>OF</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Creighton</surname><given-names>CJ</given-names></name><etal></etal></person-group>. <article-title>Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN</article-title>. <source/>Oncotarget. (<year>2018</year>) <volume>9</volume>:<fpage>14456</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.24470</pub-id><pub-id pub-id-type="pmid">29581856</pub-id></mixed-citation>
</ref>
<ref id="B144">
<label>144.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montales</surname><given-names>MTE</given-names></name><name><surname>Melnyk</surname><given-names>SB</given-names></name><name><surname>Simmen</surname><given-names>FA</given-names></name><name><surname>Simmen</surname><given-names>RCM</given-names></name></person-group>. <article-title>Maternal metabolic perturbations elicited by high-fat diet promote Wnt-1-induced mammary tumor risk in adult female offspringvialong-term effects on mammary and systemic phenotypes</article-title>. <source/>Carcinogenesis. (<year>2014</year>) <volume>35</volume>:<fpage>2102</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgu106</pub-id><pub-id pub-id-type="pmid">24832086</pub-id></mixed-citation>
</ref>
<ref id="B145">
<label>145.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benesh</surname><given-names>EC</given-names></name><name><surname>Humphrey</surname><given-names>PA</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Moley</surname><given-names>KH</given-names></name></person-group>. <article-title>Maternal high-fat diet induces hyperproliferation and alters Pten/Akt signaling in prostates of offspring</article-title>. <source/>Sci Rep. (<year>2013</year>) <volume>3</volume>:<fpage>3466</fpage>. <pub-id pub-id-type="doi">10.1038/srep03466</pub-id><pub-id pub-id-type="pmid">24322661</pub-id></mixed-citation>
</ref>
<ref id="B146">
<label>146.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Templeman</surname><given-names>NM</given-names></name><name><surname>Murphy</surname><given-names>CT</given-names></name></person-group>. <article-title>Regulation of reproduction and longevity by nutrient-sensing pathways</article-title>. <source/>J Cell Biol. (<year>2017</year>) <volume>217</volume>:<fpage>93</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201707168</pub-id><pub-id pub-id-type="pmid">29074705</pub-id></mixed-citation>
</ref>
<ref id="B147">
<label>147.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otaghi</surname><given-names>M</given-names></name><name><surname>Azami</surname><given-names>M</given-names></name><name><surname>Khorshidi</surname><given-names>A</given-names></name><name><surname>Borji</surname><given-names>M</given-names></name><name><surname>Tardeh</surname><given-names>Z</given-names></name></person-group>. <article-title>The association between metabolic syndrome and polycystic ovary syndrome: a systematic review and meta-analysis</article-title>. <source/>Diabetes Metab Syndr. (<year>2019</year>) <volume>13</volume>:<fpage>1481</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.dsx.2019.01.002</pub-id><pub-id pub-id-type="pmid">31336510</pub-id></mixed-citation>
</ref>
<ref id="B148">
<label>148.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charifson</surname><given-names>MA</given-names></name><name><surname>Trumble</surname><given-names>BC</given-names></name></person-group>. <article-title>Evolutionary origins of polycystic ovary syndrome: an environmental mismatch disorder</article-title>. <source/>Evol Med Public Health. (<year>2019</year>) <volume>2019</volume>:<fpage>50</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1093/emph/eoz011</pub-id><pub-id pub-id-type="pmid">31367382</pub-id></mixed-citation>
</ref>
<ref id="B149">
<label>149.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>S</given-names></name><name><surname>Balen</surname><given-names>AH</given-names></name></person-group>. <article-title>How will the new global polycystic ovary syndrome guideline change our clinical practice?</article-title>
<source/>Clin Med Insights Reprod Health. (<year>2019</year>) <volume>13</volume>:<fpage>117955811984960</fpage>. <pub-id pub-id-type="doi">10.1177/1179558119849605</pub-id><pub-id pub-id-type="pmid">31320811</pub-id></mixed-citation>
</ref>
<ref id="B150">
<label>150.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winship</surname><given-names>AL</given-names></name><name><surname>Gazzard</surname><given-names>SE</given-names></name><name><surname>Cullen-McEwen</surname><given-names>LA</given-names></name><name><surname>Bertram</surname><given-names>JF</given-names></name><name><surname>Hutt</surname><given-names>KJ</given-names></name></person-group>
<article-title>Maternal low-protein diet programmes low ovarian reserve in offspring</article-title>. <source/>Reproduction. (<year>2018</year>) <volume>156</volume>:<fpage>299</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1530/REP-18-0247</pub-id></mixed-citation>
</ref>
<ref id="B151">
<label>151.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group>. <article-title>Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome</article-title>. <source/>Eur J Obstet Gynecol Reprod Biol. (<year>2019</year>) <volume>233</volume>:<fpage>134</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejogrb.2018.12.010</pub-id><pub-id pub-id-type="pmid">30594023</pub-id></mixed-citation>
</ref>
<ref id="B152">
<label>152.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwase</surname><given-names>A</given-names></name><name><surname>Goto</surname><given-names>M</given-names></name><name><surname>Harata</surname><given-names>T</given-names></name><name><surname>Takigawa</surname><given-names>S</given-names></name><name><surname>Nakahara</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><etal></etal></person-group>. <article-title>Insulin attenuates the Insulin-Like Growth Factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN</article-title>. <source/>J Clin Endocrinol Metab. (<year>2009</year>) <volume>94</volume>:<fpage>2184</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2008-1948</pub-id><pub-id pub-id-type="pmid">19318457</pub-id></mixed-citation>
</ref>
<ref id="B153">
<label>153.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>H-Y</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Cahill</surname><given-names>N</given-names></name><name><surname>Richards</surname><given-names>JS</given-names></name></person-group>. <article-title>Targeted disruption of pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells</article-title>. <source/>Mol Endocrinol. (<year>2008</year>) <volume>22</volume>:<fpage>2128</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1210/me.2008-0095</pub-id><pub-id pub-id-type="pmid">18606860</pub-id></mixed-citation>
</ref>
<ref id="B154">
<label>154.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>Z-J</given-names></name><name><surname>Krause</surname><given-names>MS</given-names></name><name><surname>Redding</surname><given-names>SD</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>GZ</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name><etal></etal></person-group>. <article-title>Selective deletion of Pten in theca-interstitial cells leads to androgen excess and ovarian dysfunction in mice</article-title>. <source/>Mol Cell Endocrinol. (<year>2017</year>) <volume>444</volume>:<fpage>26</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2017.01.043</pub-id><pub-id pub-id-type="pmid">28137614</pub-id></mixed-citation>
</ref>
<ref id="B155">
<label>155.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><name><surname>Kim</surname><given-names>YY</given-names></name><name><surname>Ku</surname><given-names>SY</given-names></name></person-group>. <article-title>Animal models for human polycystic ovary syndrome (PCOS) focused on the use of indirect hormonal perturbations: a review of the literature</article-title>. <source/>Int J Mol Sci. (<year>2019</year>) <volume>20</volume>:<fpage>2720</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20112720</pub-id><pub-id pub-id-type="pmid">31163591</pub-id></mixed-citation>
</ref>
<ref id="B156">
<label>156.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafiee</surname><given-names>MN</given-names></name><name><surname>Seedhouse</surname><given-names>C</given-names></name><name><surname>Mongan</surname><given-names>N</given-names></name><name><surname>Chapman</surname><given-names>C</given-names></name><name><surname>Deen</surname><given-names>S</given-names></name><name><surname>Abu</surname><given-names>J</given-names></name><etal></etal></person-group>. <article-title>Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer</article-title>. <source/>Mol Cell Endocrinol. (<year>2016</year>) <volume>424</volume>:<fpage>94</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2016.01.019</pub-id><pub-id pub-id-type="pmid">26802879</pub-id></mixed-citation>
</ref>
<ref id="B157">
<label>157.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>ALL</given-names></name><name><surname>Faria</surname><given-names>LC</given-names></name><name><surname>Guimarães</surname><given-names>TCM</given-names></name><name><surname>Moreira</surname><given-names>GV</given-names></name><name><surname>Cândido</surname><given-names>AL</given-names></name><name><surname>Couto</surname><given-names>CA</given-names></name><etal></etal></person-group>. <article-title>Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis</article-title>. <source/>J Endocrinol Invest. (<year>2017</year>) <volume>40</volume>:<fpage>1279</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1007/s40618-017-0708-9</pub-id><pub-id pub-id-type="pmid">28612285</pub-id></mixed-citation>
</ref>
<ref id="B158">
<label>158.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SA</given-names></name><name><surname>Choi</surname><given-names>HC</given-names></name></person-group>. <article-title>Metformin inhibits inflammatory response via AMPK–PTEN pathway in vascular smooth muscle cells</article-title>. <source/>Biochem Biophys Res Commun. (<year>2012</year>) <volume>425</volume>:<fpage>866</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.07.165</pub-id><pub-id pub-id-type="pmid">22898050</pub-id></mixed-citation>
</ref>
<ref id="B159">
<label>159.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feuer</surname><given-names>SK</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Donjacour</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Simbulan</surname><given-names>RK</given-names></name><name><surname>Giritharan</surname><given-names>G</given-names></name><etal></etal></person-group>. <article-title>Use of a mouse <italic>in vitro</italic> fertilization model to understand the developmental origins of health and disease hypothesis</article-title>. <source/>Endocrinology. (<year>2014</year>) <volume>155</volume>:<fpage>1956</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1210/en.2013-2081</pub-id><pub-id pub-id-type="pmid">24684304</pub-id></mixed-citation>
</ref>
<ref id="B160">
<label>160.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>STY</given-names></name><name><surname>Andres</surname><given-names>AM</given-names></name><name><surname>Miller</surname><given-names>AK</given-names></name><name><surname>Spann</surname><given-names>NJ</given-names></name><name><surname>Potter</surname><given-names>DW</given-names></name><name><surname>Post</surname><given-names>NM</given-names></name><etal></etal></person-group>. <article-title>Txnip balances metabolic and growth signaling via PTEN disulfide reduction</article-title>. <source/>Proc Natl Acad Sci USA. (<year>2008</year>) <volume>105</volume>:<fpage>3921</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0800293105</pub-id><pub-id pub-id-type="pmid">18322014</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>